{"study_id": 53308, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "To compare the safety and effectiveness of CPAP vs. HFNC in preventing therapeutic failure and the need for invasive ventilation in children with acute moderate-severe bronchiolitis.", "results_summary": "CPAP showed a lower risk of therapeutic failure and a longer time to failure compared to HFNC, but had more adverse events like nasal injury. No differences were found in other outcomes such as need for invasive ventilation, apnea, ICU days, or length of hospitalization.", "population_specificity": "Children with moderate to severe bronchiolitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:54.227076+00:00"}
{"study_id": 53306, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of spontaneous breathing trials (SBTs) using pressure support ventilation (PSV) versus T-piece on weaning outcomes in mechanically ventilated patients.", "results_summary": "The study found no difference in successful weaning rates between PSV and T-piece groups, but PSV shortened the weaning process without increasing reintubation risks. ICU and hospital mortality and length of stay were similar between groups.", "population_specificity": "Critically ill medical patients requiring mechanical ventilation for over 24 hours in two medical ICUs.", "effective_dosage": "Pressure support of 8 cmH\u2082O (PSV group).", "study_duration": "Data collected from November 1, 2017, to September 30, 2020.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:54.443860+00:00"}
{"study_id": 53309, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the global and regional distribution of lung volumes during non-invasive high-frequency oscillatory ventilation (nHFOV) versus nasal continuous positive airway pressure (nCPAP) in preterm infants.", "results_summary": "The study found that while regional ventilation was similar between nHFOV and nCPAP, end-expiratory lung volume was higher and aeration homogeneity was slightly improved during nHFOV, particularly in non-gravity dependent regions. The clinical significance of these findings remains unclear.", "population_specificity": "Preterm infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:55.506162+00:00"}
{"study_id": 53310, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the bidirectional relationship between obstructive sleep apnea (OSA) and aldosterone levels, particularly in the context of hypertension and resistant hypertension.", "results_summary": "The study found that elevated aldosterone levels are independently associated with OSA severity in resistant hypertension, suggesting a bidirectional influence where aldosterone exacerbates OSA through fluid shifts and upper airway muscle dysfunction, contributing to hypertension.", "population_specificity": "Patients with hypertension, particularly those with resistant hypertension and coexisting OSA.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:58.044218+00:00"}
{"study_id": 53312, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the cardiovascular effects of CPAP therapy versus MAD therapy in patients with moderate obstructive sleep apnea (OSA).", "results_summary": "The study found that CPAP therapy significantly reduced the apnea-hypopnea index but showed no significant changes in major cardiovascular risk factors compared to MAD therapy after 12 months. Both treatments had similar effects on cardiovascular and metabolic outcomes.", "population_specificity": "Patients with moderate OSA (apnea-hypopnea index of 15-30 events/h).", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:58.781524+00:00"}
{"study_id": 53313, "supplement_id": 1048, "safety_score": "65", "efficacy_score": 80, "quality_score": 85, "study_goal": "To determine whether CPAP improves clinical outcomes compared to conventional oxygen therapy in hospitalized COVID-19 patients with acute hypoxemic respiratory failure.", "results_summary": "CPAP significantly reduced the risk of tracheal intubation or mortality within 30 days compared to conventional oxygen therapy, but HFNO showed no significant difference. Adverse events were more frequent with CPAP (34.2%) than with conventional oxygen therapy (13.9%).", "population_specificity": "Hospitalized adults with COVID-19-related acute hypoxemic respiratory failure (mean age 57.4 years, 66% male, 65% White).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:00.639197+00:00"}
{"study_id": 53311, "supplement_id": 1048, "safety_score": "62", "efficacy_score": 85, "quality_score": 88, "study_goal": "To determine if systemic corticosteroids and nebulized epinephrine reduce the duration of positive pressure support (including CPAP) in children with bronchiolitis compared to standard care.", "results_summary": "The combination treatment reduced the geometric mean duration of positive pressure support from 40 hours to 26 hours, with a statistically significant adjusted ratio of 0.66 (P = .001). Adverse event rates were similar between groups (38% in both).", "population_specificity": "Children younger than 18 months with bronchiolitis admitted to intensive care.", "effective_dosage": "13 mg/kg prednisolone over 3 days, then 1 mg/kg daily for 3 days; 0.05 mL/kg of 1% epinephrine nebulized every 30 minutes for 5 doses, then 1-4 hourly for 3 days, then as needed.", "study_duration": "6 days (3 days fixed regimen, 3 days as needed).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:00.908482+00:00"}
{"study_id": 53314, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine whether targeted autoregulated positive airway pressure (APAP) therapy for obstructive sleep apnea (OSA) in high-risk pregnant women reduces adverse pregnancy outcomes, costs, and OSA severity.", "results_summary": "The study found no significant difference in composite adverse pregnancy outcomes, hypertension, preterm birth, low birthweight, stillbirth, or gestational diabetes between the APAP-treated and control groups. APAP compliance was poor, and OSA severity worsened throughout pregnancy, peaking postpartum.", "population_specificity": "Pregnant women at high risk of obstructive sleep apnea.", "effective_dosage": "Not specified (APAP prescribed if Apnea Hypopnea Index \u22655 events/hour).", "study_duration": "Sleep studies conducted early (6-16 weeks) and late (27-33 weeks) in pregnancy, with follow-up 3 months postpartum.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:02.852109+00:00"}
{"study_id": 53316, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) in managing nocturia associated with obstructive sleep apnea (OSA).", "results_summary": "The study found that CPAP was effective in addressing nocturia in OSA patients, with ten studies evaluating its impact. The expert consensus recommended conservative therapy in primary care for suspected sleep disorders, with referrals for severe cases or specific conditions like REM sleep behavior disorder.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and nocturia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:02.942581+00:00"}
{"study_id": 53315, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the pathophysiology and management strategies for residual sleepiness in OSA patients adequately treated with nCPAP.", "results_summary": "The study found that wake-stimulant medications (modafinil, armodafinil, pitolisant, solriamfetol) are effective in reducing residual sleepiness in OSA patients treated with nCPAP, offering a personalized approach. Neuroimaging studies suggest structural brain changes may contribute to persistent sleepiness.", "population_specificity": "Patients with persistent sleepiness after adequate nCPAP treatment for obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:03.209247+00:00"}
{"study_id": 53317, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the role of non-invasive ventilation (NIV), particularly continuous positive airway pressure (CPAP), in managing COVID-19 patients in resource-limited ICU settings.", "results_summary": "The study found that CPAP was used as a primary treatment in a COVID-19 ICU with high patient mortality (61.1%), suggesting its feasibility in resource-constrained settings but highlighting the need for comprehensive critical care alongside ventilation.", "population_specificity": "COVID-19 patients in an ICU in Baghdad, Iraq, predominantly in a low- to middle-income country (LMIC) setting.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:04.271528+00:00"}
{"study_id": 53320, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Continuous Positive Airway Pressure (CPAP) on sympathetic nervous system activity in individuals with obstructive sleep apnea (OSA).", "results_summary": "The study found that CPAP treatment results in sympathoinhibition in OSA patients, counteracting the robust sympathoexcitation associated with the disorder. This suggests CPAP effectively reduces sympathetic overactivity linked to baroreflex and chemoreflex dysfunction.", "population_specificity": "Individuals with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:06.590154+00:00"}
{"study_id": 53321, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to update clinical guidelines for the diagnosis and treatment of sleep apnea syndrome (SAS), including the use of Continuous Positive Airway Pressure (CPAP) therapy, based on the latest trends and interdisciplinary collaboration.", "results_summary": "The abstract highlights the widespread use of CPAP therapy in Japan, with over 500,000 patients, and the development of updated guidelines to standardize care. The guidelines include 36 clinical questions, with therapies and management strategies for SAS addressed in the latter half.", "population_specificity": "Adult males and postmenopausal women with moderate-to-severe obstructive sleep apnea (OSA), primarily in Japan but also referencing Western and Eastern countries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:10.660162+00:00"}
{"study_id": 53322, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of combining the Pythagorean Self-Awareness Intervention (PSAI) with Continuous Positive Airway Pressure (CPAP) on OSA symptoms and psychological health compared to CPAP alone.", "results_summary": "The study found a statistically significant reduction in OSA symptoms, improved sleep quality, and better affect (both positive and negative) in the PSAI+CPAP group compared to CPAP alone. No side effects were reported.", "population_specificity": "Patients with obstructive sleep apnea (OSA), aged 59.7\u00b19.4 years in the intervention group and 58.9\u00b19.3 years in the control group.", "effective_dosage": "Not specified (CPAP settings not detailed).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:10.772201+00:00"}
{"study_id": 53323, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to clarify the prevalence of comorbid obstructive sleep apnea (OSA) and bradycardia and assess the effect of CPAP therapy on bradycardia outcomes.", "results_summary": "The study found a high comorbid burden between OSA and bradycardia, with CPAP treatment not significantly reducing the risk of daytime or nocturnal bradycardia compared to no treatment.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and/or bradycardia (4852 patients across 34 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:11.043573+00:00"}
{"study_id": 53326, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to assess whether adding eculizumab to standard therapy (including CPAP) improved outcomes in COVID-19 patients with respiratory dysfunction.", "results_summary": "Eculizumab treatment improved respiratory rates and reduced the combined endpoint of mortality and chronic complications compared to controls, with no significant safety concerns reported.", "population_specificity": "COVID-19 patients receiving CPAP ventilator support within \u226424 hours of admission.", "effective_dosage": "Two 900 mg doses of eculizumab (frequency not specified).", "study_duration": "Median follow-up of 47.0 (IQR 14.0-121.0) days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:12.058407+00:00"}
{"study_id": 53325, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "To evaluate whether lung reactance (Xrs) assessment by FOT within 2 hours of birth identifies preterm infants who would need surfactant within 24 hours and to determine a cut-off value for early detection.", "results_summary": "Xrs predicted surfactant need with a cut-off of -33.4 cmH2O/L/s and was associated with respiratory support duration in preterm infants. The study suggests Xrs could help individualize respiratory management.", "population_specificity": "Preterm infants born between 27-33 weeks gestational age, excluding those with endotracheal intubation at birth, major malformations, or participation in other trials.", "effective_dosage": "Nasal CPAP at 5 cmH2O.", "study_duration": "Assessment within 2 hours of birth, follow-up for 24 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:13.397686+00:00"}
{"study_id": 53328, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether routine noninvasive respiratory support (CPAP, NIV, or HFNO) reduces the incidence of pneumonia after surgery compared to standard postoperative care.", "results_summary": "The study found no significant reduction in pneumonia incidence with noninvasive respiratory support (4.9% vs. 5.5% with standard care). The results do not support routine postoperative use of CPAP, NIV, or HFNO for pneumonia prevention in adults.", "population_specificity": "Adult surgical patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:14.486574+00:00"}
{"study_id": 53331, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to compare the effectiveness and safety of CPAP/NPPV versus HFNC in treating severe bronchiolitis in infants.", "results_summary": "CPAP/NPPV showed significantly higher treatment success (70.4%) compared to HFNC (50.7%), with no differences in intubation rate or serious adverse events. Switching to CPAP/NPPV after HFNC failure avoided intubation in 54% of cases.", "population_specificity": "Infants aged 7 days to 6 months admitted for severe bronchiolitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:19.129982+00:00"}
{"study_id": 53330, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of CPAP on very elderly patients (\u226580 years old) with moderate-to-severe obstructive sleep apnea (OSA).", "results_summary": "CPAP improved snoring, witnessed apneas, and AHI but showed no significant clinical improvements in sleepiness (ESS), quality of life, neurocognitive function, mood, or blood pressure. The study concluded that CPAP use in very elderly OSA patients was not supported.", "population_specificity": "Very elderly patients (\u226580 years old) with moderate-to-severe OSA.", "effective_dosage": "Average CPAP use was 4.3 hours/night (53% adherence).", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:19.631139+00:00"}
{"study_id": 53329, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the dose-response relationship between weight loss and improvements in obstructive sleep apnea (OSA) severity in patients using Continuous Positive Airway Pressure (CPAP).", "results_summary": "The study found that weight loss, particularly \u22655% and ideally \u226510%, significantly improved respiratory events and oximetry indices in OSA patients using CPAP, with greater weight loss leading to more substantial reductions in apnea-hypopnea index (AHI).", "population_specificity": "Overweight/obese adults with moderate-to-severe obstructive sleep apnea.", "effective_dosage": "Not specified (CPAP prescription details not provided).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:19.741078+00:00"}
{"study_id": 53332, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of Continuous Positive Airway Pressure (CPAP) in treating obstructive sleep apnea (OSA) and its impact on stroke outcomes.", "results_summary": "The abstract reviews evidence suggesting CPAP treatment may improve stroke outcomes by addressing OSA, but it does not provide specific efficacy metrics or conclusive results. The manuscript discusses randomized controlled trials and observational studies but does not summarize definitive findings.", "population_specificity": "Patients with acute ischemic stroke and obstructive sleep apnea (OSA).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:20.164023+00:00"}
{"study_id": 53333, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "To examine the association between obstructive sleep apnoea and diabetic retinopathy/macular oedema, and assess the impact of CPAP treatment on diabetic eye changes.", "results_summary": "CPAP treatment was associated with a reduced likelihood of developing pre/proliferative diabetic retinopathy, though conflicting data exists regarding other sleep parameters and diabetic eye changes.", "population_specificity": "Patients with obstructive sleep apnoea and diabetic retinopathy/macular oedema.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:21.108051+00:00"}
{"study_id": 53334, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to determine whether minimally invasive surfactant therapy (MIST) administered via a thin catheter, while maintaining CPAP, improves survival without bronchopulmonary dysplasia (BPD) in preterm infants with respiratory distress syndrome.", "results_summary": "MIST did not significantly reduce the composite outcome of death or BPD compared to the control group, but it did reduce the incidence of BPD in survivors at 36 weeks' postmenstrual age. Serious adverse events were similar between groups (10.3% in MIST vs. 11.1% in control).", "population_specificity": "Preterm infants with a gestational age of 25 to 28 weeks, supported with CPAP, requiring a fraction of inspired oxygen of 0.30 or greater within 6 hours of birth.", "effective_dosage": "200 mg/kg of poractant alfa (single dose).", "study_duration": "Intervention was administered once within 6 hours of birth; follow-up continued until 36 weeks' postmenstrual age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:25.755893+00:00"}
{"study_id": 53319, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to examine the association between maternal sleep-disordered breathing (SDB) and glucose metabolism in early pregnancy, not specifically evaluating Continuous Positive Airway Pressure (CPAP).", "results_summary": "The study found an association between SDB severity (measured by REI and ODI) and insulin resistance (HOMA-IR) in early pregnancy, but CPAP was not evaluated as an intervention. OSA diagnosis (REI > 5 events/hour) was not associated with HOMA-IR after adjusting for BMI.", "population_specificity": "Pregnant women with BMI \u226527 kg/m\u00b2 and singleton pregnancies, excluding those with pregestational diabetes or CPAP use.", "effective_dosage": "Not available", "study_duration": "Not applicable (observational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:27.217935+00:00"}
{"study_id": 53337, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role and effectiveness of Continuous Positive Airway Pressure (CPAP) as a noninvasive ventilation method in perioperative settings, particularly in children.", "results_summary": "The study found that CPAP is commonly used in perioperative settings to support respiratory function, but there are limited data on its optimal use in children. Contraindications and common problems like airway leaks were noted, and high-flow nasal oxygen (HFNO) was mentioned as an alternative.", "population_specificity": "Perioperative patients, with a focus on children.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:28.320092+00:00"}
{"study_id": 53338, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) and other non-invasive ventilation strategies in reducing postoperative respiratory complications in children with neuromuscular, chronic neurologic, and chest wall diseases.", "results_summary": "The study suggests that tailored postoperative extubation plans, including avoiding CPAP trials and directly extubating to non-invasive ventilation with high inspiratory to expiratory pressure differentials, may improve outcomes in high-risk children. It highlights the need for preoperative pulmonary assessments to identify at-risk patients who may benefit from such interventions.", "population_specificity": "Children with neuromuscular, chronic neurologic, and chest wall diseases, including those with cerebral palsy and neurodegenerative or neurodevelopmental disorders.", "effective_dosage": "High inspiratory to expiratory pressure differential of at least 10 cm H2O (specific CPAP dosage not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:30.437707+00:00"}
{"study_id": 53339, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the relationship between muscle sympathetic nerve activity (MSNA) and obstructive sleep apnoea syndrome (OSAS) severity, and whether continuous positive airway pressure (CPAP) could modulate sympathetic overdrive.", "results_summary": "The study found that MSNA increases progressively with OSAS severity and is significantly related to the apnoea-hypopnea index, suggesting CPAP could be an effective therapeutic intervention to reduce sympathetic activation. Heart rate also correlated with MSNA and OSAS severity, reinforcing CPAP's potential role in sympathomodulation.", "population_specificity": "Uncomplicated OSAS patients of varying clinical severity (mild, moderate, severe).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:30.748833+00:00"}
{"study_id": 53335, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) in the escalation phase of noninvasive ventilation for pediatric respiratory failure and its integration into respiratory care progression.", "results_summary": "The study highlights CPAP as a critical step in respiratory care when high-flow nasal cannula fails, emphasizing the need for careful clinical assessment to avoid delayed escalation. It also notes ongoing research in optimizing mechanical ventilation strategies, including CPAP, to reduce complications like ventilator-induced lung injury.", "population_specificity": "Pediatric intensive care unit patients with acute respiratory or cardiorespiratory illness.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:31.090416+00:00"}
{"study_id": 53340, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate non-CPAP therapies for obstructive sleep apnoea (OSA) and update clinical guidelines based on a systematic review of the literature.", "results_summary": "The guideline provides recommendations for various non-CPAP therapies, including mandibular advancement devices, hypoglossal nerve stimulation, and positional therapy, but does not specifically report findings on CPAP's effects.", "population_specificity": "Adults with obstructive sleep apnoea (OSA).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:33.375204+00:00"}
{"study_id": 53327, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To compare the efficacy of High Flow Nasal Cannula (HFNC) as an alternative to Continuous Positive Airway Pressure (CPAP) therapy in postoperative patients with suspected moderate to severe obstructive sleep apnea (OSA).", "results_summary": "CPAP was used for fewer hours than HFNC, but there was no significant difference in oxygen desaturation events or need for additional interventions. Patients preferred HFNC due to comfort, ease of use, and perceived efficacy.", "population_specificity": "Elective surgical patients with a STOP-BANG score of 5 or higher.", "effective_dosage": "Not specified for CPAP; HFNC tested at 20 L/min, 30 L/min, and 40 L/min.", "study_duration": "First postoperative night.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:36.546292+00:00"}
{"study_id": 53341, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to assess the effects of low (\u2264 5 cm H\u2082O) versus moderate-high (> 5 cm H\u2082O) nasal CPAP levels on preterm infants for initial respiratory support and following endotracheal extubation.", "results_summary": "The study found no clear evidence that low or moderate-high nasal CPAP levels significantly improved outcomes such as death, bronchopulmonary dysplasia, or treatment failure, with very low certainty of evidence due to risk of bias and imprecise effect estimates.", "population_specificity": "Preterm infants of gestational age < 37 weeks or birth weight < 2500 grams within the first 28 days of life.", "effective_dosage": "Low (\u2264 5 cm H\u2082O) versus moderate-high (> 5 cm H\u2082O) nasal CPAP.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:37.500083+00:00"}
{"study_id": 53342, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy of non-invasive ventilation modes, including Continuous Positive Airway Pressure (CPAP), against other respiratory management strategies in adult patients with acute hypoxaemic respiratory failure (AHRF).", "results_summary": "CPAP was associated with a significantly lower risk of mortality compared to standard oxygen therapy (SOT) and had the highest probability of being the best intervention for reducing short-term mortality among all evaluated strategies. However, no non-invasive respiratory management strategy was significantly better than invasive mechanical ventilation (IMV) in reducing mortality.", "population_specificity": "Adult patients with de novo acute hypoxaemic respiratory failure (AHRF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:37.946797+00:00"}
{"study_id": 53336, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) in improving symptoms of PTSD, particularly sleep disruption.", "results_summary": "The study suggests that treating sleep disruption, including sleep apnea with CPAP, may improve PTSD symptoms and mood in anxiety disorders. CPAP was mentioned as part of a broader treatment approach but without detailed efficacy data specific to CPAP.", "population_specificity": "Patients with PTSD and related anxiety disorders, particularly those experiencing sleep disruption.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:38.291963+00:00"}
{"study_id": 53343, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to highlight the effectiveness of Continuous Positive Airway Pressure (CPAP) as a treatment for obstructive sleep apnea (OSA) and its role in reducing associated health risks.", "results_summary": "The abstract states that CPAP is one of the most common and effective treatments for OSA, which helps mitigate risks like diabetes, hypertension, stroke, and heart failure. However, no specific efficacy data or comparative results are provided.", "population_specificity": "Adults with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:38.406813+00:00"}
{"study_id": 53344, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to explore alternative treatments for obstructive sleep apnoea (OSA) beyond the traditional CPAP-focused approach, focusing on precision medicine and personalised treatment allocation.", "results_summary": "The study highlights that CPAP is often inadequate for many patients and discusses emerging non-CPAP therapies, such as mandibular advancement devices, upper airway surgery, and hypoglossal nerve stimulation, as well as potential physiological barriers to CPAP adherence.", "population_specificity": "Patients with obstructive sleep apnoea (OSA)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:39.153829+00:00"}
{"study_id": 53345, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 82, "quality_score": 68, "study_goal": "To determine the clinical profile and outcome of children requiring noninvasive ventilation (NIV) in a PICU, focusing on success rates and predictors of failure.", "results_summary": "NIV was successful in 81.7% of cases, with failure linked to sepsis with MODS, acidosis, and moderate-to-severe ARDS. The most common diagnoses were tropical fever, bronchopneumonia, and sepsis with MODS.", "population_specificity": "Children aged 1 month to 18 years with moderate-to-severe respiratory distress in a PICU setting.", "effective_dosage": "BiPAP with inspiratory and expiratory positive airway pressure (8-18 cm H2O).", "study_duration": "One-year study period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:40.119692+00:00"}
{"study_id": 53346, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combining CPAP with a low-calorie ketogenic diet (LCKD) before bariatric surgery improves obstructive sleep apnea (OSAS) more than CPAP alone in patients with obesity and OSAS.", "results_summary": "CPAP significantly improved AHI scores, but combining it with LCKD showed no additional advantage on AHI. However, CPAP+LCKD significantly reduced body weight, CRP levels, blood pressure, and lipid profiles compared to CPAP alone.", "population_specificity": "Seventy patients with obesity and OSAS scheduled for bariatric surgery.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:42.043304+00:00"}
{"study_id": 53347, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to identify potential biomarkers for OSA diagnosis and evaluate the impact of CPAP treatment on the metabolomic and lipidomic profile of OSA patients.", "results_summary": "CPAP treatment was associated with changes in 5 plasma metabolites previously altered by OSA, suggesting a modulation of the molecular fingerprint of OSA. The study also identified a 4-metabolite signature with high accuracy for OSA detection.", "population_specificity": "206 consecutive subjects referred to a sleep unit with suspected OSA (defined as AHI \u2265 15 events/h).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:44.725609+00:00"}
{"study_id": 53348, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of CPAP therapy on circulating levels of ICAM-1, VCAM-1, and E-selectin in patients with obstructive sleep apnea (OSA).", "results_summary": "CPAP therapy significantly reduced ICAM-1 and E-selectin levels but did not significantly improve VCAM-1 levels in OSA patients. The findings suggest ICAM-1 and E-selectin may be useful markers for evaluating CPAP's cardiovascular risk reduction benefits.", "population_specificity": "650 patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:45.954268+00:00"}
{"study_id": 53349, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the limitations of CPAP in treating obstructive sleep apnea (OSA) and its impact on cardiovascular outcomes, while comparing its effectiveness to mandibular advancement devices (MADs).", "results_summary": "CPAP showed poor patient acceptance and adherence, with average usage below the recommended 4 hours per night, leading to reduced effectiveness in cardiovascular risk reduction. Despite being more efficacious than MADs in abolishing apnea events, CPAP's low adherence resulted in comparable improvements in quality-of-life and cardiovascular measures when compared to MADs.", "population_specificity": "Patients affected by obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:46.922311+00:00"}
{"study_id": 53351, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the utility, safety, and outcome benefits of non-invasive respiratory support (NIRS), including Continuous Positive Airway Pressure (CPAP), in managing COVID-19-associated acute respiratory failure.", "results_summary": "The study found that NIRS, including CPAP, was safe, improved resource utilization, and might be associated with better outcomes in COVID-19 patients. Survival rates were higher among patients receiving NIRS, and complication rates were low.", "population_specificity": "Patients with COVID-19-associated acute respiratory failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:46.988223+00:00"}
{"study_id": 53352, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to compare the positive airway pressures and expired gas washout generated by nasal high flow (NHF) therapy versus CPAP in child nasal airway replicas.", "results_summary": "NHF therapy at 20 L/min generated average PEEP similar to CPAP at 5 cmH2O, suggesting comparable efficacy in airway pressure generation. The study did not report significant differences in expired gas washout between the two therapies.", "population_specificity": "Child nasal airway replicas (not human subjects).", "effective_dosage": "CPAP at 5 cmH2O; NHF at 20 L/min.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:48.015391+00:00"}
{"study_id": 53350, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the mechanisms, safety, and effectiveness of nasal continuous positive airway pressure (nCPAP) and high-flow nasal cannula (HFNC) in preterm infants with respiratory distress syndrome.", "results_summary": "The study found that nCPAP is preferred over HFNC as the primary mode of noninvasive respiratory support for preterm infants with respiratory distress syndrome, while HFNC is an effective alternative post-extubation. The abstract also discusses device characteristics, failure risks, and adverse effects.", "population_specificity": "Preterm infants with respiratory distress syndrome in the neonatal intensive care unit.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:48.225626+00:00"}
{"study_id": 53353, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not primarily investigate Continuous Positive Airway Pressure (CPAP) but rather examines the effects of late systemic postnatal corticosteroids on preterm infants with evolving or established bronchopulmonary dysplasia (BPD).", "results_summary": "The study does not provide specific findings on CPAP; it focuses on corticosteroids reducing mortality and BPD in preterm infants without increasing cerebral palsy.", "population_specificity": "Preterm infants with evolving or established BPD.", "effective_dosage": "Not mentioned for CPAP.", "study_duration": "Not mentioned for CPAP.", "interactions": "None mentioned for CPAP.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:48.559997+00:00"}
{"study_id": 53354, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of obstructive sleep apnea (OSA) in cardiovascular diseases and the benefits of continuous positive airway pressure (CPAP) on blood pressure and cardiovascular risk.", "results_summary": "The study found that OSA contributes to hypertension and cardiovascular disease progression, and CPAP therapy significantly improves daytime blood pressure and reduces cardiovascular risk.", "population_specificity": "Individuals with obstructive sleep apnea, particularly those with or at risk for cardiovascular diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:49.663103+00:00"}
{"study_id": 53355, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "To determine if a care bundle combined with CPAP in the PACU improves rapid recovery after pulmonary tumor resection.", "results_summary": "The PACU experimental group showed improved respiratory status monitoring time and blood gas parameters, accelerating postoperative rehabilitation compared to control groups. The OR group had higher intraoperative blood transfusion volume, urine volume, and other parameters.", "population_specificity": "135 patients requiring anesthesia resuscitation after pulmonary tumor resection.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:52.132489+00:00"}
{"study_id": 53356, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of continuous positive airway pressure (CPAP) on splanchnic capacitance and compliance, and its interaction with sublingual nitroglycerin (SL NTG) in reducing left ventricular preload.", "results_summary": "The study found that CPAP, combined with SL NTG, increased splanchnic capacitance and compliance while proportionally decreasing pulmonary blood volume, suggesting a mechanism for LV preload reduction.", "population_specificity": "Subjects without heart failure.", "effective_dosage": "0.6 mg SL NTG (single dose).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:54.431721+00:00"}
{"study_id": 53358, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of CPAP, BPAP-BUR, TPNS, and ASV in reducing AHI and improving ESS in patients with HFrEF and CSA.", "results_summary": "CPAP showed a statistically significant reduction in AHI compared to GDMT but was less effective than ASV and TPNS. CPAP did not significantly improve ESS compared to GDMT or other interventions.", "population_specificity": "Patients with heart failure with reduced ejection fraction (HFrEF) and central sleep apnea (CSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:55.572102+00:00"}
{"study_id": 53357, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of mandibular advancement device therapy on left ventricular geometry and function in patients with obstructive sleep apnea (OSA).", "results_summary": "The study found significant reverse hypertrophic remodeling of the left ventricle after 6 months of successful mandibular advancement device therapy in mildly obese, normotensive OSA patients, with maintained normotensive systemic blood pressure. This suggests OSA is an independent factor in the pathophysiology of left ventricular hypertrophy.", "population_specificity": "Mildly obese, normotensive patients with obstructive sleep apnea (age: 49 \u00b1 11 years; BMI: 27.0 \u00b1 3.4 kg/m\u00b2).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:56.037141+00:00"}
{"study_id": 53360, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "To investigate the safety and efficacy of surfactant therapy in late preterm and term infants with respiratory distress syndrome (RDS).", "results_summary": "Surfactant use was associated with a decreased risk of mortality and reduced need for invasive mechanical ventilation, though evidence certainty varied from moderate to very low. Further trials are needed due to inconsistent thresholds for surfactant administration.", "population_specificity": "Late preterm (LPT) and term infants with respiratory distress syndrome (RDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:56.257566+00:00"}
{"study_id": 53359, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the benefits and possible harms of noninvasive respiratory support, including Continuous Positive Airway Pressure (CPAP), for COVID-19 respiratory failure.", "results_summary": "CPAP was used with variable success rates in COVID-19 patients with hypoxemic respiratory failure, but the risk of treatment failure was higher in patients with severe oxygenation impairment (PaO2/FiO2 < 200 mmHg). The study highlighted the need for careful monitoring to avoid delays in intubation.", "population_specificity": "COVID-19 patients with hypoxemic respiratory failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:56.542093+00:00"}
{"study_id": 53361, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effectiveness and cost-effectiveness of an intelligent monitoring system (MiSAOS) for improving CPAP compliance in patients with obstructive sleep apnea (OSA).", "results_summary": "The study found that the MiSAOS system increased daily CPAP compliance by 1.14 hours/day compared to standard management, with excellent patient satisfaction and no significant cost differences, demonstrating cost-effectiveness.", "population_specificity": "60 newly diagnosed OSA patients (mean age 57, 13% women) with an Apnea-Hypopnea Index (AHI) >15 from Lleida, Spain.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:57.839311+00:00"}
{"study_id": 53362, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine if prophylactic or very early nasal CPAP reduces mechanical ventilation use and bronchopulmonary dysplasia incidence in preterm infants without adverse effects.", "results_summary": "Prophylactic CPAP likely reduces BPD and mechanical ventilation need compared to supportive care or mechanical ventilation, with no significant difference in death or neurodevelopmental impairment. Evidence for CPAP vs. very early CPAP was inconclusive.", "population_specificity": "Preterm infants (under 37 weeks of gestation).", "effective_dosage": "Not specified (timing: within first 15 minutes or first hour of life).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:58.336040+00:00"}
{"study_id": 53363, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the impact of a peer-driven intervention on promoting the resumption of CPAP use in patients with severe obstructive sleep apnea who had discontinued treatment.", "results_summary": "The study anticipates that 20% of patients in the intervention group will resume CPAP use compared to 6% in the control group, with secondary aims focusing on adherence, patient satisfaction, and feasibility of the peer-driven intervention.", "population_specificity": "Adult outpatients with severe obstructive sleep apnea (Apnoea-Hypopnoea Index >30 events/hour) who stopped using CPAP within 4-12 months after initiation.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:01.004665+00:00"}
{"study_id": 53364, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the effectiveness of a stage-matched intervention (HAPA) on adherence to mandibular advancement appliances (MAA) in patients with obstructive sleep apnoea (OSA), comparing it to standard care.", "results_summary": "The study does not report results for Continuous Positive Airway Pressure (CPAP) but focuses on MAA adherence using a behavioral intervention. Data collection for MAA adherence was planned at 3, 6, 18, and 36 months.", "population_specificity": "Patients with newly diagnosed obstructive sleep apnoea (OSA).", "effective_dosage": "Not mentioned", "study_duration": "Data collection planned up to 36 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:03.080025+00:00"}
{"study_id": 53365, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effectiveness of helmet CPAP (hCPAP) and high flow nasal cannula (HFNC) in the early treatment of acute cardiogenic pulmonary oedema (ACPO).", "results_summary": "hCPAP was more effective than HFNC in reducing respiratory rate, heart rate, and improving PaO2/FiO2 ratio, HACOR scores, and Dyspnoea Scale, but no differences in intubation rate were observed.", "population_specificity": "Patients admitted to the emergency department due to ACPO with hypoxemia and dyspnoea on face mask oxygen therapy.", "effective_dosage": "FiO2 set to achieve arterial oxygen saturation >94%.", "study_duration": "1 hour of treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:04.570452+00:00"}
{"study_id": 53367, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether home sleep apnea testing (HSAT) increased OSA diagnosis and treatment rates, improved clinical outcomes, and was cost-effective compared to in-laboratory polysomnography (iPSG) in stroke/transient ischemic attack patients.", "results_summary": "HSAT significantly increased OSA diagnosis rates (48.8% vs. 35.2%) and treatment initiation, reduced daytime sleepiness, improved functional outcomes, and enhanced patient experiences compared to iPSG. It was also deemed a cost-effective approach.", "population_specificity": "Patients who had sustained a stroke or transient ischemic attack within the past 6 months.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:05.163210+00:00"}
{"study_id": 53368, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the relationship between muscle sympathetic nerve activity (MSNA) and obstructive sleep apnea syndrome (OSAS) severity, and whether continuous positive airway pressure (CPAP) could modulate sympathetic overdrive.", "results_summary": "The study found that MSNA increases progressively with OSAS severity and is significantly related to the apnea-hypopnea index (AHI) and oxygen saturation, but not to body weight or BMI. Heart rate also correlated with MSNA and AHI, suggesting CPAP could target sympathetic overdrive.", "population_specificity": "Uncomplicated OSAS patients of varying clinical severity (850 participants from 26 microneurographic studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:05.801802+00:00"}
{"study_id": 53369, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the indications, procedural measures, and ventilatory strategies of bronchoscopy, including the use of Continuous Positive Airway Pressure (CPAP), in different settings during the COVID-19 pandemic.", "results_summary": "The abstract mentions that CPAP, non-invasive ventilation support, and high-flow nasal cannula oxygen are frequently used in COVID-19 patients, but it does not provide specific results on CPAP's efficacy or safety. The focus is on bronchoscopy practices and ventilatory strategies rather than CPAP outcomes.", "population_specificity": "Patients affected by Coronavirus disease 2019 (COVID-19), particularly those requiring bronchoscopy or ventilatory support.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:07.189250+00:00"}
{"study_id": 53366, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess whether montelukast, compared to placebo, improves cognitive function (processing speed), sleep, and reduces adenoidal size and white matter damage in young children with sickle cell anaemia (SCA) and sleep-disordered breathing (SDB).", "results_summary": "The abstract does not provide results regarding Continuous Positive Airway Pressure (CPAP), as the study focuses on montelukast. CPAP is mentioned as a common but poorly tolerated treatment for SDB, but its efficacy and safety are not evaluated in this study.", "population_specificity": "Young children (aged 3-7.99 years) with sickle cell anaemia (SCA) and sleep-disordered breathing (SDB).", "effective_dosage": "Not mentioned for CPAP.", "study_duration": "Not mentioned for CPAP.", "interactions": "None mentioned for CPAP.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:07.818109+00:00"}
{"study_id": 53370, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether CPAP ventilation and passive CPAP oxygenation in children could delay a decrease in SpO2 to 95% after apnea onset compared to a standard technique without positive airway pressure.", "results_summary": "CPAP significantly delayed the time until SpO2 decreased to 95% (median difference: 154 s) and resulted in fewer primary events (50% vs. 94.1%) compared to the control group. SpO2 levels remained significantly higher in the CPAP group between 60 and 210 seconds post-apnea onset.", "population_specificity": "68 children aged 2-6 years with ASA I-II undergoing surgery under general anesthesia.", "effective_dosage": "Not specified", "study_duration": "Follow-up period of 300 seconds from apnea onset.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:08.078976+00:00"}
{"study_id": 53371, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the long-term effects of CPAP therapy adherence on blood pressure in OSA patients, while accounting for potential confounding by body weight changes.", "results_summary": "Good CPAP adherence over 24 months was associated with a significant reduction in diastolic blood pressure, but no significant effect on weight loss was observed.", "population_specificity": "918 OSA patients from a Kanagawa-area sleep clinic.", "effective_dosage": "Hours of CPAP usage collected over 30 nights prior to each follow-up visit (specific hours not quantified).", "study_duration": "24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:09.013055+00:00"}
{"study_id": 53373, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of different oxygenation strategies, including CPAP, during flexible fiberoptic bronchoscopy (FOB) to prevent desaturation episodes.", "results_summary": "CPAP and NIV showed improved oxygenation outcomes compared to HFNC, particularly in patients with severe hypoxemic acute respiratory failure during FOB.", "population_specificity": "Patients undergoing flexible fiberoptic bronchoscopy, especially those with acute respiratory failure or hypoxemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:10.461330+00:00"}
{"study_id": 53375, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate whether CPAP training could reduce hypernasality in children with infantile-onset Pompe disease (IOPD).", "results_summary": "CPAP training significantly improved hypernasality, speech intelligibility, and consonant accuracy during the intervention phase, though consonant accuracy returned to baseline levels after follow-up. The study suggests CPAP may be effective in reducing nasal sounds in IOPD patients.", "population_specificity": "Five children with infantile-onset Pompe disease (IOPD).", "effective_dosage": "8-week, 6-day-per-week CPAP training regimen at home.", "study_duration": "8 weeks of CPAP training, with a total study duration of 24 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:13.910953+00:00"}
{"study_id": 53374, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Continuous Positive Airway Pressure (CPAP) as a noninvasive treatment for severe upper airway obstruction in infants and children with craniofacial malformations, reducing the need for surgery or tracheostomy.", "results_summary": "CPAP was found to be an effective treatment for severe upper airway obstruction in children with craniofacial malformations, reducing the necessity for surgical interventions or tracheostomy. Follow-up and monitoring strategies varied but benefited from built-in software data analysis to assess adherence and breathing parameters, minimizing the need for in-hospital sleep studies.", "population_specificity": "Infants and children with craniofacial malformations and obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:14.033676+00:00"}
{"study_id": 53376, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Continuous Positive Airway Pressure (CPAP) improves cognitive functions in patients with obstructive sleep apnea (OSA) who have mild cognitive impairment (MCI) or Alzheimer's disease (AD).", "results_summary": "The study found that CPAP treatment mildly but significantly improved cognitive functions in OSA patients with MCI or AD, particularly with long-term use, as measured by the Mini-Mental State Examination (MMSE). However, no significant cognitive benefits were detected using the Montreal Cognitive Assessment.", "population_specificity": "OSA patients with mild cognitive impairment (MCI) or Alzheimer's disease (AD).", "effective_dosage": "Not specified", "study_duration": "Not specified (long-term CPAP treatment showed better results)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:14.858026+00:00"}
{"study_id": 53377, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of telemedicine-based interventions (TM) in improving CPAP adherence among patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis of 16 RCTs found that TM increased CPAP adherence by 29.2 minutes per night, with 12 out of 16 studies showing low risk of bias. The certainty of evidence was rated according to GRADE, supporting the effectiveness of TM in enhancing CPAP adherence.", "population_specificity": "Patients with obstructive sleep apnea (OSA) (3039 participants across 16 RCTs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:15.417137+00:00"}
{"study_id": 53378, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether CPAP reduces cardiovascular events in older adults with moderate obstructive sleep apnea.", "results_summary": "The study found no significant difference in cardiovascular event occurrence between CPAP-treated and standard-of-care groups, with a relative risk of 1.05 (95% CI, 0.60-1.83). CPAP did not reduce CVE probability in this population.", "population_specificity": "Older adults (>70 years) with moderate OSA (apnea-hypopnea index 15.0-29.9 events/h).", "effective_dosage": "Not specified", "study_duration": "Mean follow-up of 47 months (interquartile range: 29.6-64.0 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:16.661123+00:00"}
{"study_id": 53379, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of high-flow nasal cannula (HFNC) versus continuous positive airway pressure (CPAP) in reducing the risk of bronchopulmonary dysplasia (BPD) in premature newborns.", "results_summary": "The study found no significant difference between HFNC and CPAP in terms of BPD risk, air leak syndrome, or nasal trauma, with a very low level of evidence supporting these outcomes.", "population_specificity": "Premature infants born at less than 37 weeks of gestational age.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:17.232421+00:00"}
{"study_id": 53380, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the physiologic rationale, risks, and benefits of using HFNC compared to conventional oxygen therapy and other noninvasive respiratory support devices like Continuous Positive Airway Pressure in COVID-19 patients with acute hypoxemic respiratory failure.", "results_summary": "The abstract does not provide specific findings about Continuous Positive Airway Pressure but highlights the effectiveness and tolerability of HFNC, along with concerns about infection transmission to healthcare workers. It also notes controversial recommendations from different scientific societies regarding noninvasive respiratory support.", "population_specificity": "Patients affected by COVID-19 pneumonia with associated acute hypoxemic respiratory failure.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:17.611527+00:00"}
{"study_id": 53381, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the improvement in quality of life among patients with obstructive sleep apnea (OSA) treated with mandibular advancement appliances as an alternative to continuous positive airway pressure (CPAP).", "results_summary": "The study found a significant improvement in quality of life, measured by the Functional Outcomes of Sleep Questionnaire (FOSQ), with a mean difference of 1.8 points between baseline and post-treatment scores in patients using oral appliance therapy.", "population_specificity": "Patients with obstructive sleep apnea (OSA) treated with mandibular advancement appliances.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:18.525033+00:00"}
{"study_id": 53383, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to analyze the differences in OSA pathogenesis in Chinese patients and assess the current state of personalized medicine for OSA in China, including the efficacy and acceptance of CPAP.", "results_summary": "The study found that CPAP is the first-line and most efficacious treatment for OSA, but its acceptance is unacceptably low in China. It highlighted the need for targeted therapies due to ethnic differences in OSA risk factors.", "population_specificity": "Chinese patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:21.702240+00:00"}
{"study_id": 53382, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to characterize pulmonary sequelae caused by SARS-CoV-2 pneumonia at 6-month follow-up, including the impact of different ventilatory support methods like Continuous Positive Airway Pressure (CPAP).", "results_summary": "The study found that CPAP was one of the ventilatory support methods used, but the abstract does not detail specific outcomes for CPAP alone. DLCO impairment and chest X-ray abnormalities were common, but dyspnea and restrictive ventilatory defects were less frequent.", "population_specificity": "Hospitalized patients with SARS-CoV-2 pneumonia and no prior structural lung diseases.", "effective_dosage": "Not specified", "study_duration": "6-month follow-up from discharge", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:22.665535+00:00"}
{"study_id": 53385, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to summarize the technical aspects of using a helmet device for delivering noninvasive ventilatory support, including Continuous Positive Airway Pressure (CPAP) and Noninvasive Positive Pressure Ventilation (NPPV).", "results_summary": "The abstract mentions the use of a helmet device for delivering CPAP and NPPV but does not provide specific results regarding efficacy or outcomes. It focuses on technical aspects and CO2 prevention.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:23.366460+00:00"}
{"study_id": 53386, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the blood pressure-lowering effects of CPAP treatment in adult patients with uncontrolled hypertension and moderate-to-severe obstructive sleep apnea.", "results_summary": "The study found that CPAP treatment was evaluated for its impact on brachial and central blood pressure, as well as hypertension-mediated organ damage, though final results were not fully reported due to pandemic-related sample size limitations.", "population_specificity": "Adult patients with uncontrolled hypertension (using at least one antihypertensive medication) and moderate-to-severe obstructive sleep apnea (AHI \u226515 events/hour).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:25.192507+00:00"}
{"study_id": 53384, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of Fixed Pressure CPAP and Auto-adjusting Pressure CPAP in treating symptomatic obstructive sleep apnoea (OSA) and to determine patient preference between the two methods.", "results_summary": "The study found that Fixed CPAP may be considered as first-line therapy for symptomatic moderate and severe OSA, particularly for patients with titrated optimal CPAP pressure less than 8 cmH2O and BMI less than 32.3 kg/m\u00b2. The results suggest a preference or efficacy difference between the two CPAP methods, though specific outcomes are not detailed in the abstract.", "population_specificity": "Adult subjects with symptomatic OSA attending a respiratory clinic at Universiti Kebangsaan Malaysia Medical Centre (UKMMC).", "effective_dosage": "Not specified", "study_duration": "The study was conducted from February 2018 to February 2019 (exact intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:25.193746+00:00"}
{"study_id": 53389, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the relationship between circulating SOD levels and OSA, and whether CPAP treatment affects these levels.", "results_summary": "The study found that OSA patients had significantly lower SOD levels compared to controls, but short-term CPAP treatment (4-12 weeks) did not significantly alter SOD levels.", "population_specificity": "1240 patients with OSA and 457 controls.", "effective_dosage": "Not specified", "study_duration": "4-12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:25.740745+00:00"}
{"study_id": 53388, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether nasal pathology affects CPAP use, the effect of CPAP on the nose, and whether treating nasal pathology impacts CPAP use.", "results_summary": "Larger nasal cross-sectional area or lower nasal resistance correlated with higher CPAP compliance, while nasal symptoms at baseline did not significantly affect CPAP use. CPAP may increase nasal inflammation, but its effect on symptoms is inconsistent. Nasal surgery improved CPAP compliance, but topical nasal steroids showed little evidence of benefit.", "population_specificity": "Not specified (general CPAP users, inferred from systematic review scope).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:26.067421+00:00"}
{"study_id": 53387, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether cardiopulmonary exercise testing (CPET) could characterize patients with OSA and evaluate the effect of nasal CPAP therapy.", "results_summary": "The study found that untreated OSA patients had lower aerobic and exercise capacity, while nasal CPAP therapy improved these parameters. Patients receiving CPAP showed better oxygen uptake and exercise tolerance compared to untreated OSA patients.", "population_specificity": "Patients with moderate to severe obesity and suspected OSA (94 with AHI \u226515 events/h, 53 controls with AHI <15 events/h).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:26.976150+00:00"}
{"study_id": 53391, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify predictors of poor outcomes, including the use of continuous positive airway pressure (CPAP), in younger adults hospitalized for COVID-19.", "results_summary": "CPAP was part of a composite poor outcome measure, but the study did not isolate its specific effects. Poor outcomes (including CPAP use) were associated with factors like heart disease, low oxygen saturation, and high LDH.", "population_specificity": "Adults aged 18-65 hospitalized for COVID-19 pneumonia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:30.866883+00:00"}
{"study_id": 53392, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To identify COVID-19 patients in the emergency department who require early CPAP using vital signs measurements during triage.", "results_summary": "The study found that patients requiring early CPAP were typically male, older, with lower oxygen saturation, higher temperature, elevated respiratory rate, and pre-hospital oxygen therapy. A triage flow chart was proposed to identify these patients.", "population_specificity": "COVID-19 patients admitted to the emergency department of a university hospital in Lombardy, Italy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:30.885188+00:00"}
{"study_id": 53390, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether adherence to CPAP therapy in OSA patients is associated with a reduction in all-cancer incidence compared to nonadherent patients.", "results_summary": "The study found no significant impact of CPAP adherence on all-cause cancer risk, with similar cancer incidence rates between adherent and nonadherent groups. Further evaluation is needed to assess if CPAP therapy might reduce the risk of specific cancer sites.", "population_specificity": "Patients with obstructive sleep apnea (OSA) prescribed CPAP therapy, with no history of cancer before the diagnostic sleep study or during the first year of CPAP.", "effective_dosage": "CPAP use \u22654 hours per night defined adherence.", "study_duration": "Median follow-up of 5.4 years (interquartile range 3.1-8.0).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:31.283272+00:00"}
{"study_id": 53393, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review novel interventions targeting upper airway muscles to alleviate OSA severity, as continuous positive airway pressure (CPAP) is often poorly tolerated.", "results_summary": "The abstract highlights that CPAP, while a leading treatment for OSA, is frequently poorly tolerated, prompting exploration of alternative treatments like hypoglossal nerve stimulation, myofunctional therapy, and pharmacotherapy (e.g., norepinephrine reuptake inhibitors combined with antimuscarinics).", "population_specificity": "Patients with obstructive sleep apnoea (OSA).", "effective_dosage": "Not specified for CPAP.", "study_duration": "Not specified for CPAP.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:34.346736+00:00"}
{"study_id": 53394, "supplement_id": 1048, "safety_score": "40", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the association between different initial respiratory support modalities (including CPAP) and outcomes in preterm infants under 32 weeks of gestation.", "results_summary": "CPAP failure was associated with significantly higher risks of mortality, pneumothorax, pulmonary hemorrhage, and bronchopulmonary dysplasia (BPD), with risks comparable to initial mechanical ventilation. The incidence of CPAP failure was 10.3% among preterm infants.", "population_specificity": "Preterm infants delivered at less than 32 weeks of gestation in multiple NICUs in China.", "effective_dosage": "Not specified", "study_duration": "12 months (study period, not intervention duration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:35.162312+00:00"}
{"study_id": 53396, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess changes in non-invasive ventilation (NIV) use, including CPAP, in preterm infants and its impact on clinical outcomes.", "results_summary": "CPAP use increased significantly from 2010 to 2017, and HFNC use was associated with reduced mortality but higher rates of bronchopulmonary dysplasia (BPD). Infants on CPAP alone died earlier than those also receiving HFNC.", "population_specificity": "Infants born at <32 weeks' gestation admitted to neonatal units in England and Wales.", "effective_dosage": "Not specified", "study_duration": "Data collected from 2010 to 2017, but individual intervention duration not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:35.629146+00:00"}
{"study_id": 53397, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to compare the efficacy and safety of solriamfetol, modafinil, and armodafinil in treating excessive daytime sleepiness associated with obstructive sleep apnea in patients using continuous positive airway pressure.", "results_summary": "The study found that solriamfetol, modafinil, and armodafinil all improved outcomes on the ESS, MWT20, and CGI-C scales compared to placebo, with solriamfetol showing the highest probabilities of improvement. Safety risks were similar across treatments, with low rates of serious or discontinuation-related adverse events.", "population_specificity": "Patients with excessive daytime sleepiness associated with obstructive sleep apnea who were treated with continuous positive airway pressure.", "effective_dosage": "Solriamfetol (150 mg or 300 mg), modafinil (200 mg or 400 mg), armodafinil (dosage not specified).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:37.673286+00:00"}
{"study_id": 53399, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy of positional device therapy as an alternative treatment for positional obstructive sleep apnea (POSA) in children who do not tolerate continuous positive airway pressure (CPAP) therapy.", "results_summary": "The study found that positional device therapy significantly reduced the obstructive apnea-hypopnea index (OAHI) and decreased the percentage of total sleep time in the supine position, though improvements in the oxygen desaturation index were not statistically significant.", "population_specificity": "Children aged 4-18 years with positional obstructive sleep apnea (POSA) and an OAHI \u2265 5 events/hour.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:40.024675+00:00"}
{"study_id": 53400, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the duration of oxygen therapy when using two different weaning methods from nasal continuous positive airway pressure (nCPAP) in very preterm babies.", "results_summary": "The study found no difference in the duration of oxygen therapy between the two weaning methods. However, weaning by nasal high-flow therapy (nHFT) was associated with better parental perceptions of infant comfort and lower rates of severe nasal injury.", "population_specificity": "Preterm infants <32 weeks gestation and birthweight >1,000 g.", "effective_dosage": "Not specified (nCPAP weaning methods compared).", "study_duration": "At least 7 days on nCPAP before weaning.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:40.240333+00:00"}
{"study_id": 53398, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the attitudes and clinical practices regarding the use of noninvasive ventilation (NIV), including Continuous Positive Airway Pressure (CPAP), in managing acute chest syndrome (ACS) in pediatric ICUs.", "results_summary": "CPAP was used in 17% of ACS cases, making it the second most common NIV method after BiPAP. The study noted BiPAP as the predominant choice, especially in centers frequently managing ACS patients, but did not directly compare efficacy or safety between CPAP and other methods.", "population_specificity": "Pediatric ICU patients with sickle cell disease (SCD) presenting with acute chest syndrome (ACS).", "effective_dosage": "Not specified", "study_duration": "Median PICU stay for ACS was 5 days (IQR: 3.1).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:40.500629+00:00"}
{"study_id": 53401, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the frequency, characteristics, and outcomes of attacks requiring ventilatory support (including Continuous Positive Airway Pressure) in patients with MOGAD and AQP4-NMOSD.", "results_summary": "Attacks requiring ventilatory support were rare in both MOGAD (2.9%) and AQP4-NMOSD (2.2%) patients, with differing indications and higher morbidity/mortality in AQP4-NMOSD, particularly among Black individuals.", "population_specificity": "Patients with MOGAD or AQP4-NMOSD experiencing attacks requiring noninvasive (bilevel positive airway pressure or continuous positive airway pressure) or invasive respiratory support.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:43.210389+00:00"}
{"study_id": 53402, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the clinical response to CPAP therapy in patients with COPD-obstructive sleep apnea overlap syndrome (OVS) versus obstructive sleep apnea (OSA) alone.", "results_summary": "CPAP therapy effectively normalized the apnea-hypopnea index and improved OSA-related symptoms in both groups, though OVS patients had higher odds of persistent morning headaches, tiredness, daytime sleepiness, and exertional dyspnea compared to OSA patients.", "population_specificity": "6,320 patients with moderate-to-severe OSA, including those with and without COPD (OVS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:43.834970+00:00"}
{"study_id": 53403, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of Continuous Positive Airway Pressure (CPAP) on glycemic variability (GV) and high blood glucose index during sleep in patients with obstructive sleep apnea syndrome (OSA) and normal glucose tolerance.", "results_summary": "CPAP treatment for 1 week significantly improved GV during sleep, reducing the standard deviation of GV and high blood glucose index. The study also found correlations between GV indexes and sleep-related breathing disorder metrics, with the rapid eye movement-related OSA group showing a higher incidence of hypoglycemia.", "population_specificity": "42 patients with OSA and no diabetes.", "effective_dosage": "Not specified", "study_duration": "1 week", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:44.296228+00:00"}
{"study_id": 53404, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To assess the effects of chronic non-invasive ventilation (NIV) via a facial mask in people with COPD, comparing it to standard care, focusing on outcomes like arterial blood gases, quality of life, and survival.", "results_summary": "Chronic NIV improves daytime hypercapnia in COPD patients, with potential survival benefits in stable COPD and prolonged admission-free survival post-exacerbation, though HRQL benefits were short-term or absent.", "population_specificity": "People with COPD, both stable and post-severe exacerbation.", "effective_dosage": "At least five hours per night for three consecutive weeks or more.", "study_duration": "Outcomes assessed after three and 12 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:46.816431+00:00"}
{"study_id": 53407, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the role of oxidative stress biomarkers in assessing OSA severity and treatment response, particularly focusing on the effects of CPAP therapy.", "results_summary": "CPAP reduces intermittent hypoxia, reoxygenation, and nighttime arousals, demonstrating anti-inflammatory properties and decreased oxidative stress. However, the role of supplemental compounds like vitamins and N-acetylcysteine in OSA treatment remains unclear.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:48.405636+00:00"}
{"study_id": 53405, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) as the first-line treatment for Obstructive Sleep Apnea (OSA) and compare it with upper airway surgery for patients who refuse or cannot tolerate CPAP.", "results_summary": "CPAP is recognized as the standard first-line treatment for OSA, while upper airway surgery is recommended for patients who cannot tolerate CPAP. Surgical outcomes depend on identifying the site and pattern of airway collapse and the balance of anatomical and non-anatomical factors.", "population_specificity": "Patients with Obstructive Sleep Apnea (OSA), particularly those with mild upper airway collapsibility or tissue obstruction.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:49.162214+00:00"}
{"study_id": 53406, "supplement_id": 1048, "safety_score": "65", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety and efficacy of high flow nasal oxygen compared to other oxygen therapies, including nasal continuous positive airway pressure, in COVID-19-positive or suspected patients.", "results_summary": "The study found that high flow nasal oxygen generates aerosol dispersion similar to standard oxygen therapies and less than nasal continuous positive airway pressure with ill-fitting masks. It supports the use of high flow nasal oxygen in high-risk patients to extend time to desaturation, with precautions.", "population_specificity": "COVID-19-positive or suspected adult patients, particularly those with morbid obesity, predicted difficult airways, or significant hypoxaemia.", "effective_dosage": "High flow nasal oxygen with flow rates up to 60 l/min.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:49.557962+00:00"}
{"study_id": 53409, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of telemedicine in managing patients using Continuous Positive Airway Pressure (CPAP), focusing on data transmission, troubleshooting, and patient empowerment.", "results_summary": "The study found that telemedicine-ready CPAP devices enable early troubleshooting and personalized feedback, improving patient engagement and comanagement. Telemedicine is likely cost-effective but requires further evidence for broader implementation.", "population_specificity": "Patients using Continuous Positive Airway Pressure (CPAP).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:51.450601+00:00"}
{"study_id": 53408, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of CPAP delivered via a single-limb intentional leak configuration in treating COVID-19 patients, as well as healthcare worker safety.", "results_summary": "The study found that the CPAP configuration allowed for reliable tidal volume monitoring with median overall leaks of 68 L/min, though specific efficacy outcomes were not detailed. Safety for healthcare workers was also assessed, but patient safety data was not explicitly reported.", "population_specificity": "COVID-19 patients (median age 67, 85.7% male) in a respiratory intermediate care unit.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:53.124473+00:00"}
{"study_id": 53410, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of CPAP treatment on cortisol levels and blood pressure in individuals with obstructive sleep apnoea (OSA).", "results_summary": "CPAP treatment in individuals with OSA reduced cortisol levels and blood pressure, as evidenced by a meta-analysis of 22 studies, including 16 prospective cohort studies and 6 randomized control trials.", "population_specificity": "Individuals with obstructive sleep apnoea (OSA), mean age range 41-62 years, BMI range 27.2-35.1 kg/m\u00b2.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:53.369494+00:00"}
{"study_id": 53411, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the relationship between OSA severity and nocturnal blood pressure (NBP) parameters, and the effect of short-term CPAP therapy on NBP.", "results_summary": "The study found that OSA severity was associated with increased NBP and NBP fluctuations, and CPAP therapy reduced NBP parameters after the first night.", "population_specificity": "548 patients from a cardiac clinic with suspected OSA.", "effective_dosage": "Not specified", "study_duration": "Short-term (first night)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:54.524886+00:00"}
{"study_id": 53395, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "To investigate whether a hydrocolloid nasal dressing reduces nasal injury and CPAP failure in preterm infants receiving nasal CPAP.", "results_summary": "The intervention group had significantly lower incidence and severity of nasal injury (37.5% vs. 92.5%) compared to the control group, with mostly mild to moderate injuries. No significant difference in CPAP failure was observed.", "population_specificity": "Preterm infants born at \u226432 weeks gestation and/or with a birth weight \u22641,500 g receiving nasal CPAP.", "effective_dosage": "Not specified", "study_duration": "Between 4 and 72 hours of CPAP", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:54.706105+00:00"}
{"study_id": 53412, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the gene expression patterns in whole blood of patients with OSA before and after CPAP treatment to understand its effects on immune-related genes and identify potential biomarkers.", "results_summary": "CPAP treatment initially restored downregulated immune-related genes in OSA patients after three months, but gene expression returned to untreated levels after 12 months. The study also highlighted the importance of BMI-matched controls for accurate comparisons.", "population_specificity": "Thirty patients with untreated moderate-severe OSA, 20 BMI/age/sex-matched controls, and 15 normal-weight controls.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:57.104383+00:00"}
{"study_id": 53414, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to provide clinical guidance on identifying, evaluating, and managing excessive daytime sleepiness (EDS) in patients with obstructive sleep apnea (OSA) treated with continuous positive airway pressure (CPAP).", "results_summary": "The study highlights that EDS persists in some CPAP-treated OSA patients despite normalized breathing and sleep quality, and it offers recommendations for assessment and management, including pharmacotherapy and specialist referrals.", "population_specificity": "Patients with obstructive sleep apnea (OSA) experiencing excessive daytime sleepiness (EDS) despite CPAP therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:57.689983+00:00"}
{"study_id": 53415, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the impact of a noninvasive respiratory support algorithm, including CPAP combined with HFNC, on clinical outcomes in COVID-19 patients with acute respiratory failure.", "results_summary": "Combined noninvasive respiratory support (CPAP plus HFNC) was feasible and resulted in a 73.45% success rate, with an intubation rate of 26.54% and overall mortality of 14.15%. The ROX index at 12 hours (6.28) predicted noninvasive support failure with high sensitivity (97.6%).", "population_specificity": "113 subjects with COVID-19 respiratory failure admitted to a respiratory intermediate care unit.", "effective_dosage": "Not specified", "study_duration": "June to December 2020 (intervention duration per patient not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:00.765880+00:00"}
{"study_id": 53416, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the links between endotypic traits of obstructive sleep apnoea (OSA) and the effectiveness of non-CPAP treatment options, including how these traits could predict therapy success.", "results_summary": "The abstract summarizes available evidence on the relationship between OSA endotypic traits (e.g., pharyngeal collapsibility, neuromuscular compensation) and non-CPAP treatments, highlighting the potential for tailored therapies but noting implementation challenges. It does not directly report CPAP-specific results.", "population_specificity": "Patients with obstructive sleep apnoea (OSA).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:02.085000+00:00"}
{"study_id": 53418, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether helmet-delivered CPAP (hCPAP) was non-inferior to facemask CPAP (fCPAP) in treating acute respiratory failure in emergency department patients.", "results_summary": "Both hCPAP and fCPAP reduced respiratory rate, heart rate, and improved dyspnea and arterial oxygenation, with hCPAP showing greater comfort and lower intubation rates.", "population_specificity": "Patients presenting to the emergency department with acute respiratory failure (acute cardiogenic pulmonary edema or decompensated COPD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:02.766414+00:00"}
{"study_id": 53419, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the impact of a multidimensional treatment framework involving shared decision-making, patient activation, and caregiver engagement on improving long-term PAP adherence in newly diagnosed obstructive sleep apnea patients.", "results_summary": "The intervention group showed significantly increased mean daily PAP use over three time periods compared to the control group, with the beneficial effect sustained for 6 months. Caregiver engagement and a supportive environment were found to improve PAP adherence.", "population_specificity": "Adults aged \u226518 years with a new obstructive sleep apnea diagnosis, qualifying for PAP treatment, and living with a caregiver.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:03.328102+00:00"}
{"study_id": 53417, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the cost-effectiveness of nasal continuous positive airway pressure (CPAP) versus nasal high-flow (nHF) therapy for treating respiratory distress in newborns in nontertiary special care nurseries.", "results_summary": "CPAP was found to be more effective and cheaper when used as sole primary support, while nHF with backup CPAP showed equivalent cost and effectiveness outcomes. The study concluded that CPAP should be chosen if only one mode is available, but nHF with backup CPAP is acceptable in units with both options.", "population_specificity": "Newborn infants (\u226531 weeks' gestation, birth weight \u22651200 g, <24 hours old) with respiratory distress requiring noninvasive respiratory support and/or supplemental oxygen for >1 hour.", "effective_dosage": "Not specified", "study_duration": "Until infants were 12 months of age (follow-up period).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:03.713883+00:00"}
{"study_id": 53420, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Nasal High-Frequency Oscillatory Ventilation (NHFOV) reduced the intubation rate compared to Nasal Continuous Positive Airway Pressure (NCPAP) as primary respiratory support in preterm infants with Respiratory Distress Syndrome (RDS).", "results_summary": "NHFOV resulted in significantly lower intubation rates compared to NCPAP (RR 0.44; 95% CI 0.29-0.67, P = 0.0002), with no heterogeneity among trials.", "population_specificity": "Preterm infants with Respiratory Distress Syndrome (RDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:05.854190+00:00"}
{"study_id": 53421, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of non-invasive respiratory support, including Continuous Positive Airway Pressure, in managing acute hypoxemic respiratory failure and acute respiratory distress syndrome, focusing on its potential to avoid intubation and associated complications.", "results_summary": "Non-invasive respiratory support improves oxygenation and protects the lungs and diaphragm, potentially avoiding intubation, but vigorous inspiratory effort may cause additional lung damage (patient self-inflicted lung injury). Strategies like high-flow nasal oxygen or helmet-delivered positive end-expiratory pressure may mitigate these risks.", "population_specificity": "Patients with acute hypoxemic respiratory failure and acute respiratory distress syndrome in the intensive care unit.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:06.826900+00:00"}
{"study_id": 53413, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of three ventilation modes (BIPAP, CPAP, and VCV) during CPR using an automated mechanical chest compression device.", "results_summary": "CPAP resulted in significantly lower tidal volumes compared to BIPAP, but all ventilation modes achieved adequate respiratory minute volume during CPR. BIPAP was deemed superior due to higher tidal volume, reducing risks related to dead space ventilation.", "population_specificity": "Patients with out-of-hospital cardiac arrest receiving chest compressions via AMCCD with an expected continuation of at least 15 minutes.", "effective_dosage": "Not specified", "study_duration": "At least 15 minutes of CPR", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:06.965741+00:00"}
{"study_id": 53423, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the bi-directional relationships between comorbid insomnia and sleep apnea (COMISA) and refine understanding for improved diagnostic and treatment approaches.", "results_summary": "The study reviewed evidence on COMISA, highlighting its greater morbidity and treatment challenges, and proposed a conceptual model to guide future research and tailored therapies.", "population_specificity": "Patients with comorbid insomnia and obstructive sleep apnea (COMISA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:09.420893+00:00"}
{"study_id": 53422, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness and safety of nasal duo positive airway pressure (N-DUOPAP) versus nasal continuous positive airway pressure (NCPAP) in treating respiratory distress syndrome in premature infants.", "results_summary": "The study found no significant difference in treatment failure rates between N-DUOPAP and NCPAP within the first 72 hours, but N-DUOPAP showed advantages in reduced non-invasive ventilation time, oxygen therapy duration, surfactant re-dosing, and hospitalization length. No significant differences were observed in adverse events like PDA, pneumothorax, IVH, BPD, apnea, or mortality.", "population_specificity": "148 premature neonates (gestational age 28-34 weeks) with respiratory distress syndrome.", "effective_dosage": "Not specified", "study_duration": "First 72 hours after birth", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:10.638420+00:00"}
{"study_id": 53426, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) in treating obstructive sleep apnea (OSA) and its associated cardiovascular effects.", "results_summary": "CPAP effectively reduces blood pressure and is essential for managing atrial fibrillation in OSA patients. The treatment addresses physiological changes caused by intermittent hypoxia, such as hypertension and cardiac complications.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:11.109251+00:00"}
{"study_id": 53425, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers were attempting to determine the association between obstructive sleep apnea (OSA) and cognitive dysfunction, and the potential impact of Continuous Positive Airway Pressure on these cognitive domains.", "results_summary": "The study found that OSA is strongly associated with cognitive dysfunction, particularly affecting executive function, attention, verbal/visual long-term memory, visuospatial/constructional ability, and information processing, while language, psychomotor function, and short-term memory are less affected. Increased accumulation of A\u00df was also noted.", "population_specificity": "Individuals with obstructive sleep apnea (OSA).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:11.979552+00:00"}
{"study_id": 53424, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if improvements in sleep quality (measured via cardiopulmonary coupling-analysis) influenced serum adiponectin levels and glycemic metabolism in patients with cardiovascular disease and moderate-severe sleep apnea using Continuous Positive Airway Pressure (CPAP) and other interventions.", "results_summary": "Improvements in sleep quality were associated with higher serum adiponectin levels and better glycemic metabolism, irrespective of the therapy (CPAP, NSO, or HLSE). A unit increase in sleep quality index correlated with increased adiponectin and decreased insulin levels.", "population_specificity": "Patients with cardiovascular disease and moderate-severe sleep apnea (n = 241 with good-quality ECG signal).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:13.266584+00:00"}
{"study_id": 53427, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the benefits and prescribing considerations of Continuous Positive Airway Pressure (CPAP) for treating obstructive sleep apnea, particularly in elderly individuals.", "results_summary": "The study found that CPAP improves sleepiness, quality of life, hypertension control, arrhythmias, cardiovascular risk, and mortality in adults with obstructive sleep apnea. It also highlights specific considerations for elderly patients.", "population_specificity": "Adults, with specific mention of elderly individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:13.809847+00:00"}
{"study_id": 53428, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effects of Continuous Positive Airway Pressure (CPAP) on hearing impairment in patients with sensorineural hearing loss (SNHL) and sleep-disordered breathing (SDB).", "results_summary": "The study found that baseline hearing thresholds at multiple frequencies were associated with factors like age, gender, and comorbidities. CPAP treatment was evaluated over time, but specific efficacy results were not detailed in the abstract.", "population_specificity": "77 subjects with SNHL and SDB (60.7 \u00b1 11.1 years), including 28 who received CPAP treatment (63.0 \u00b1 8.5 years).", "effective_dosage": "Not specified", "study_duration": "Assessments at baseline, 3, 6, and 12 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:16.315693+00:00"}
{"study_id": 53429, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review Belgian data on CPAP users and their adherence over an 11-year period to assess the effectiveness of the Belgian diagnostic and treatment model.", "results_summary": "The study found that CPAP adherence in Belgium was significantly higher than in the United States, with a termination rate of 12.4% compared to 31.1%. The researchers attributed this to Belgium's stringent diagnostic and treatment model, which includes in-hospital polysomnography, strict follow-up, and multidisciplinary care.", "population_specificity": "Belgian patients treated with CPAP for moderate-to-severe obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "11 years (2008-2018)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:17.221653+00:00"}
{"study_id": 53430, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of continuous positive airway pressure (CPAP) versus bilevel positive airway pressure (BiPAP) in treating hypoventilation disorder in patients with obesity and obstructive airway disease.", "results_summary": "Both CPAP and BiPAP improved hypercapnic respiratory failure, but BiPAP showed greater efficacy in reducing PaCO\u2082. The study did not report significant adverse effects for either modality.", "population_specificity": "Patients with stable chronic hypercapnic respiratory failure, obesity (mean BMI 43 \u00b1 7 kg/m\u00b2), and obstructive airway disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:18.026673+00:00"}
{"study_id": 53433, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy and safety of sequential mechanical ventilation (including Continuous Positive Airway Pressure) in treating tuberculosis patients with respiratory failure.", "results_summary": "Sequential MV, including Continuous Positive Airway Pressure, was effective in treating tuberculosis-related respiratory failure, reducing invasive ventilation time and ventilator-associated adverse events compared to conventional MV.", "population_specificity": "44 tuberculosis patients diagnosed with respiratory failure.", "effective_dosage": "Not specified (ventilation modality switched to oronasal face mask Continuous Positive Airway Pressure until weaning).", "study_duration": "Not specified (until weaning).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:20.201549+00:00"}
{"study_id": 53432, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare higher CPAP pressures (9-11 cm H2O) with standard pressures (6-8 cm H2O) to determine their impact on extubation failure in extremely preterm infants.", "results_summary": "The study is a randomized controlled trial comparing CPAP pressures of 10 cm H2O (intervention) and 7 cm H2O (control) to assess extubation failure rates within 7 days. Results are pending as the study is ongoing.", "population_specificity": "Extremely preterm infants born before 28 weeks' gestation requiring mechanical ventilation.", "effective_dosage": "CPAP 10 cm H2O (intervention) or CPAP 7 cm H2O (control).", "study_duration": "7 days post-extubation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:20.866235+00:00"}
{"study_id": 53431, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether adding oropharyngeal exercise (OPE) to continuous positive airway pressure (CPAP) therapy improves outcomes in patients with moderate to severe obstructive sleep apnea (OSA).", "results_summary": "The study found that combining OPE with CPAP improved respiratory muscle strength (MVV, MIP, MEP), sleep quality (PSQI), and health-related quality of life (SF-36) while reducing neck circumference and BMI in the exercise group compared to controls.", "population_specificity": "Adults (mean age 51.9) diagnosed with moderate to severe OSA, predominantly male.", "effective_dosage": "Not specified (OPE regimen details not provided).", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:21.207457+00:00"}
{"study_id": 53434, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether early treatment with CPAP improves nutritional intake and in-hospital growth rates in extremely preterm infants.", "results_summary": "The study found no significant difference in growth rates between infants treated with early CPAP and those treated with early intubation. Higher growth rates from day 21 to day 28 were associated with better cognitive outcomes at 18-22 months, but this was independent of treatment group.", "population_specificity": "Extremely preterm infants (24-27 weeks gestational age).", "effective_dosage": "Not specified", "study_duration": "From birth to 36 weeks postmenstrual age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:21.659719+00:00"}
{"study_id": 53436, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 20, "quality_score": 90, "study_goal": "The researchers aimed to determine whether immediate postoperative CPAP could prevent pneumonia, endotracheal re-intubation, or death within 30 days after major abdominal surgery.", "results_summary": "CPAP did not reduce the incidence of the composite primary outcome compared to usual care (8.1% vs. 8.2%). Adverse events, though mostly mild, occurred in 8.9% of CPAP-treated patients, including claustrophobia and oronasal dryness.", "population_specificity": "Patients aged 50+ undergoing elective major open abdominal surgery.", "effective_dosage": "CPAP administered within 4 hours post-surgery (specific pressure/frequency not detailed).", "study_duration": "Intervention duration not explicitly stated; outcomes assessed within 30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:24.702398+00:00"}
{"study_id": 53439, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether CPAP usage in patients with CAD and OSA reduces the risk of cardiovascular events and death.", "results_summary": "The study found that CPAP treatment could decrease the risk of major adverse cardiovascular events (MACE), including all-cause death, cardiovascular death, myocardial infarction, stroke, and repeat revascularization in adults with CAD and OSA. However, the effects of CPAP on cardiovascular outcomes remain controversial.", "population_specificity": "Adults with coronary artery disease (CAD) and obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:24.984492+00:00"}
{"study_id": 53437, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) in treating obstructive sleep apnea (OSA) and its associated cardiovascular risks.", "results_summary": "The study found that CPAP should be offered to patients with severe OSA, while oral appliances are an alternative for mild to moderate cases or CPAP-intolerant patients. Follow-up testing is recommended to assess treatment effectiveness.", "population_specificity": "Patients with OSA, particularly those with cardiovascular conditions such as hypertension, heart failure, coronary artery disease, and atrial fibrillation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:25.252826+00:00"}
{"study_id": 53440, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the therapeutic effects of high-flow nasal cannula (HFNC) to continuous positive airway pressure (CPAP) in treating obstructive sleep apnea (OSA).", "results_summary": "CPAP was superior to HFNC in reducing respiratory events (lower AHI) and improving sleep efficiency. HFNC improved AHI but did not enhance sleep quality.", "population_specificity": "Patients with obstructive sleep apnea (AHI > 5 events/h).", "effective_dosage": "Not specified", "study_duration": "Two nights (one night per treatment)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:26.072627+00:00"}
{"study_id": 53441, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to compare the effectiveness of BiPAP versus CPAP in preterm infants with RDS after INSURE treatment, focusing on reintubation rates and other clinical outcomes.", "results_summary": "The study found no significant difference in reintubation rates between CPAP and BiPAP groups, but BiPAP resulted in shorter durations of PAP therapy and oxygen supplementation. No differences were observed in BPD, NEC, ROP, or lung function at one year.", "population_specificity": "Preterm infants with birth weight <1500 g and respiratory distress syndrome (RDS) post-INSURE treatment.", "effective_dosage": "Not specified", "study_duration": "Varied (CPAP group: 15.3 days, BiPAP group: 12.6 days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:29.652357+00:00"}
{"study_id": 53444, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate a novel device enabling selective lobe ventilation and recruitment, including Continuous Positive Airway Pressure (CPAP) for lower lobes, to address lung heterogeneity and improve ventilation in acute respiratory distress syndrome.", "results_summary": "The study reports initial testing of a device that allows selective lobe ventilation and recruitment, including CPAP for lower lobes, showing potential benefits in customizing ventilation parameters and preventing ventilator-induced lung injury. Further research is needed to confirm clinical efficacy.", "population_specificity": "Not specified (initial in vitro, ex vivo, and in vivo testing).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:30.307026+00:00"}
{"study_id": 53443, "supplement_id": 1048, "safety_score": "90", "efficacy_score": 70, "quality_score": 75, "study_goal": "To evaluate the safety and efficacy of aerosolised surfactant (SF-RI 1) delivered via nCPAP and a breath synchronisation device (AeroFact) in preterm infants with respiratory distress syndrome (RDS).", "results_summary": "The study found no safety issues with the AeroFact system. In part 2, 29% of treated infants met failure criteria compared to 48% of historical controls, showing a trend toward reduced failure rates (p=0.10).", "population_specificity": "Preterm infants (26-30 weeks gestation) with RDS requiring nCPAP.", "effective_dosage": "Part 1: single dose of 216 mg/kg; Part 2: up to four doses of aerosolised surfactant.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:30.591834+00:00"}
{"study_id": 53442, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether a new respiratory support system with low imposed work of breathing and short binasal prongs reduces delivery room intubations or death compared to a standard T-piece system with a face mask in preterm infants.", "results_summary": "The new respiratory support system significantly reduced delivery room intubation or death within 30 minutes of birth (33.1% vs. 45.1% with standard care), with an adjusted odds ratio of 0.53 (95% CI, 0.30-0.94; P = .03). No significant differences were observed in secondary outcomes or safety variables.", "population_specificity": "Extremely preterm infants (mean gestational age 25.9 weeks) in neonatal intensive care units across 5 European countries.", "effective_dosage": "Continuous positive airway pressure for 10 to 30 minutes, with positive pressure ventilation if needed.", "study_duration": "72 hours after intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:31.711052+00:00"}
{"study_id": 53445, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether sacubitril-valsartan (SV) impacts sleep apnoea (SA) in patients with chronic heart failure and reduced ejection fraction (HFrEF).", "results_summary": "The study found that SV treatment for 3 months was associated with a significant decrease in the Apnoea-Hypopnoea Index (AHI), supporting guideline recommendations to optimize HFrEF treatment in patients with central SA. A potential positive airway pressure-sparing effect was noted but requires further investigation.", "population_specificity": "Ambulatory HFrEF patients who remained symptomatic despite optimal treatment.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:33.067638+00:00"}
{"study_id": 53446, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the molecular mechanisms of obstructive sleep apnea (OSA) and the effects of CPAP treatment on endothelial function, cardiovascular risk, and platelet/erythrocyte activity.", "results_summary": "The study found that CPAP treatment improves endothelial function and may reduce cardiovascular risk in comorbidities like diabetes, atherosclerosis, hypertension, and atrial fibrillation. It also highlighted OSA's role in promoting oxidative stress, inflammation, and altered blood component function, increasing stroke risk.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and associated comorbidities (e.g., diabetes, hypertension, atherosclerosis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:33.855447+00:00"}
{"study_id": 53447, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether neonatal respiratory morbidity, including the use of Continuous Positive Airway Pressure (CPAP), differs by race in late preterm infants.", "results_summary": "The study found that late preterm respiratory morbidity was similar between racial groups, with no significant differences in the primary outcome after adjusting for confounders. CPAP use was part of the composite outcome, but the study did not isolate its individual efficacy.", "population_specificity": "Late preterm infants (34+0 to 36+6 weeks gestation) born to women at high risk for late preterm delivery.", "effective_dosage": "Not specified", "study_duration": "Outcomes assessed within the first 72 hours after birth.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:33.985637+00:00"}
{"study_id": 53448, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to analyze mortality and intubation rates in COVID-19 patients treated with NIV or CPAP to assess their efficacy and safety.", "results_summary": "CPAP and NIV were frequently used but associated with high mortality (35.1% for NIV vs. 22.2% for CPAP). Non-invasive respiratory support failed in 47.7% of patients, with 26.5% intubated and 40.9% dying.", "population_specificity": "COVID-19 patients with acute respiratory failure (4776 patients, 66% males, 46% with hypertension).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:34.550744+00:00"}
{"study_id": 53452, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) as the primary treatment for Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS), particularly in obese patients.", "results_summary": "CPAP remains the treatment of choice for most OSAHS patients, effectively addressing upper airway obstruction during sleep. The study highlights its use alongside weight reduction and other interventions like mandibular advancement devices and surgery.", "population_specificity": "Patients with Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS), particularly those with central obesity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:38.923711+00:00"}
{"study_id": 53450, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "To evaluate the effects and safety of continuous positive airway pressure (CPAP) for initial respiratory management of bronchiolitis in children.", "results_summary": "CPAP reduced hospital length of stay, respiratory rate, PaCO2, heart rate, and mechanical ventilation while increasing PaO2, but did not improve SpO2 or pH. Compared to high-flow nasal cannula, CPAP reduced treatment failure but did not decrease PICU length of stay, intubation incidence, respiratory rate, or Modified Woods Clinical Asthma Score.", "population_specificity": "Children with bronchiolitis", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:39.705572+00:00"}
{"study_id": 53456, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of CPAP in managing postoperative hypoxemia compared to other oxygen therapies.", "results_summary": "The abstract suggests CPAP is discussed as a viable option for postoperative hypoxemia management, but specific efficacy results are not detailed. The recommendations are based on available evidence, implying some level of effectiveness.", "population_specificity": "Postoperative patients with hypoxemia.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:41.365090+00:00"}
{"study_id": 53453, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine factors associated with mortality in critically ill African COVID-19 patients, including the impact of respiratory support interventions like Continuous Positive Airway Pressure (CPAP).", "results_summary": "CPAP was independently associated with higher mortality (odds ratio 3.93; 2.13-7.26), suggesting it was less effective or potentially harmful in this critically ill population compared to other interventions. The study did not explore CPAP's efficacy in improving patient outcomes.", "population_specificity": "Critically ill African adults (aged 18+) with suspected or confirmed COVID-19 admitted to intensive or high-care units across 64 hospitals in ten African countries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:41.405825+00:00"}
{"study_id": 53455, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of high-flow nasal cannula (HFNC) with continuous positive airway pressure (CPAP) as primary respiratory support in preterm infants.", "results_summary": "The meta-analysis found that HFNC had a higher risk of treatment failure compared to CPAP (RR=1.34), but no difference in intubation rates and a lower rate of nasal trauma. The study suggests HFNC could be used as primary respiratory support in preterm infants despite the higher failure risk.", "population_specificity": "Preterm infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:41.863208+00:00"}
{"study_id": 53454, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to highlight the link between sleep disordered breathing (SDB) and stroke and assess the potential benefits of Continuous Positive Airway Pressure (CPAP) in reducing stroke risk and improving neurological outcomes.", "results_summary": "The study found that CPAP treatment for SDB may reduce stroke risk and improve neurological outcomes post-stroke, suggesting early intervention is beneficial. SDB is an independent risk factor for stroke, and CPAP may mitigate associated risks like intermittent hypoxemia and systemic inflammation.", "population_specificity": "Stroke survivors with sleep disordered breathing (SDB).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:42.996296+00:00"}
{"study_id": 53457, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "To evaluate the effect of CPAP therapy on 24-hour intraocular pressure (IOP) patterns in patients with severe obstructive sleep apnea syndrome (OSAS).", "results_summary": "Most patients with severe OSAS exhibited nocturnal IOP peaks, and CPAP therapy was associated with an additional increase in IOP during the initial phase of nocturnal acrophase. Significant differences were observed at specific time intervals (20, 25, 30, and 55 minutes) after CPAP initiation.", "population_specificity": "22 newly diagnosed patients with severe OSAS.", "effective_dosage": "Not specified", "study_duration": "Two 24-hour monitoring sessions (before and after CPAP initiation).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:43.303860+00:00"}
{"study_id": 53459, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify the top 100 influential manuscripts on obstructive sleep apnea (OSA) and analyze their characteristics, including the role of Continuous Positive Airway Pressure (CPAP) in treatment and outcomes.", "results_summary": "The most cited manuscript (Marin, J.M et al., Lancet 2005) analyzed long-term cardiovascular outcomes in men with OSA, comparing those with and without CPAP treatment. The study found that treatments, including CPAP, were a prevalent subject among the top 100 influential manuscripts, indicating its significance in OSA management.", "population_specificity": "Men with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:48.235384+00:00"}
{"study_id": 53458, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if home-based auto-titrating CPAP (APAP) initiation with telemonitoring was non-inferior to standard in-lab management for compliance and quality of life in obstructive sleep apnea (OSA) patients.", "results_summary": "Home-based APAP initiation with telemonitoring was feasible and showed non-inferiority to standard in-lab management in therapy compliance, with significantly faster access to therapy (7.6 vs. 46.1 days). The pre-specified non-inferiority margin of 0.3 h/day was not met, but significance was achieved with a 0.5 h/day margin.", "population_specificity": "Patients with moderate-to-severe obstructive sleep apnea (OSA) documented by polygraphy (PG).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:48.869944+00:00"}
{"study_id": 53451, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the global heterogeneity in the use and outcomes of respiratory support methods, including CPAP, for COVID-19 patients.", "results_summary": "CPAP was used in 2% of patients overall, with specific mortality rates for CPAP/NIV reported at 29%. The study found that CPAP and NIV were less frequently applied compared to IMV, and data on their outcomes were often under-reported.", "population_specificity": "287,359 COVID-19 patients (57.5% male, mean age 64 years) from 17 countries, with 33.3% hospitalized in ICUs.", "effective_dosage": "Not specified", "study_duration": "Median hospital stay was 13 days (range: 6-63).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:48.933048+00:00"}
{"study_id": 53460, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether CPAP treatment affects urinary albumin-to-creatinine ratio (UACR) in subjects with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found that CPAP therapy significantly reduced UACR in subjects with OSA (SMD = 0.415, p = 0.037). Subgroup analyses showed the effect was consistent regardless of sample size, BMI, age, or AHI.", "population_specificity": "Subjects with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:49.726730+00:00"}
{"study_id": 53461, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of high-flow humidified oxygen (HFHO) versus continuous positive airway pressure (CPAP) in improving oxygenation while maintaining nonventilated lung collapse during one-lung ventilation.", "results_summary": "Both CPAP and HFHO increased arterial oxygen levels, but the improvements were not statistically significant. CPAP worsened surgical conditions in half the patients, while HFHO either improved or had no effect on lung deflation.", "population_specificity": "28 patients undergoing elective thoracotomy with one-lung ventilation using a double-lumen endobronchial tube.", "effective_dosage": "Not specified", "study_duration": "20 minutes per intervention with a 20-minute recovery interval.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:50.504503+00:00"}
{"study_id": 53462, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate CPAP adherence and its association with blood pressure and pulse rate changes in patients with obstructive sleep apnoea syndrome (OSAS) and hypertension.", "results_summary": "CPAP adherence was associated with blood pressure lowering and pulse rate slowing effects, particularly with higher CPAP frequency. Non-adherence was defined as CPAP use for <5 days/week or <4 hours/night.", "population_specificity": "Patients with obstructive sleep apnoea syndrome (OSAS) and hypertension.", "effective_dosage": "CPAP frequency per week and time per night (non-adherence defined as <5 days/week or <4 hours/night).", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:50.701104+00:00"}
{"study_id": 53463, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to determine whether treating sleep apnoea with CPAP slows the progression of kidney failure in patients with chronic kidney disease.", "results_summary": "The study primarily focused on recruitment challenges rather than CPAP's effects, noting that only 57 out of 1,665 eligible patients were randomized due to various barriers. No results on CPAP's impact on kidney function were reported in the abstract.", "population_specificity": "Adult patients with chronic kidney disease (CKD) and sleep apnoea.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:50.784604+00:00"}
{"study_id": 53464, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to compare the effectiveness and safety of surfactant administration via thin catheter versus endotracheal tube or continuation of non-invasive respiratory support (CPAP) in preterm infants with or at risk of respiratory distress syndrome (RDS).", "results_summary": "Surfactant administration via thin catheter significantly reduced the risk of death or bronchopulmonary dysplasia, decreased the need for intubation within 72 hours, and lowered the incidence of severe complications compared to endotracheal tube administration. The procedure showed similar adverse effect rates to endotracheal tube administration.", "population_specificity": "Preterm infants (<37 weeks' gestation) with or at risk of RDS.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:52.399670+00:00"}
{"study_id": 53467, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the cognitive effects of untreated OSA and assess the benefits of CPAP treatment across cognitive domains.", "results_summary": "CPAP treatment appears to mitigate and slow cognitive decline in OSA patients, particularly in attention, vigilance, and information processing speed, and may reduce dementia risk. Larger controlled studies are needed to confirm these effects.", "population_specificity": "Older patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:56.588997+00:00"}
{"study_id": 53465, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to study the impact of CPAP on chest anatomy and tumor motion in patients receiving radiation therapy, assessing its potential to reduce lung and heart toxicity.", "results_summary": "CPAP significantly increased lung volume by 37% and demonstrated volumetric and dosimetric benefits compared to free breathing (FB). It was well tolerated by most patients, with only 3 withdrawing due to discomfort.", "population_specificity": "Patients with primary or secondary lung tumors, left-sided breast cancer, or liver metastases referred for radiation therapy.", "effective_dosage": "Maximal pressure of 15 cm H\u2082O via face mask.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:56.718876+00:00"}
{"study_id": 53466, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare leakage between two neonatal CPAP interfaces (prongs and nasal mask) and evaluate the effectiveness of leak-corrective manoeuvres.", "results_summary": "Prongs showed significantly lower leakage compared to nasal masks, and leak-corrective manoeuvres reduced leakage for both interfaces. Large leakages were common but less pronounced with prongs.", "population_specificity": "Newborn infants with CPAP, stable spontaneous breathing, low oxygen requirement, postmenstrual age over 28 weeks, and no comorbidities (n=50).", "effective_dosage": "Not specified", "study_duration": "Data collected between August 2018 and October 2019 (exact intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:57.399876+00:00"}
{"study_id": 53471, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To determine the effect of CPAP on gait control in severe obstructive sleep apnea syndrome (OSAS) patients.", "results_summary": "The study assessed gait parameters under single and dual-task conditions before and after an 8-week CPAP intervention, with stride-time variability as the primary endpoint. Secondary outcomes included changes in gait control determinants.", "population_specificity": "24 severe OSAS patients (median age 59.5 years, 87.5% male, BMI 28.2 kg/m\u00b2).", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:59.099496+00:00"}
{"study_id": 53468, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the role of non-invasive respiratory support, including Continuous Positive Airway Pressure, in clinical conditions, particularly focusing on challenges and innovations in low- and middle-income countries.", "results_summary": "The study found that non-invasive respiratory support reduces the need for invasive mechanical ventilation, lowers the risk of nosocomial pneumonia, and decreases mortality in selected pediatric and adult populations. However, most studies are from high-income countries, highlighting a gap in data and resources for low- and middle-income countries.", "population_specificity": "Pediatric and adult populations, particularly in low- and middle-income countries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:59.392412+00:00"}
{"study_id": 53470, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the characteristics and management of respiratory failure in moderate-to-late preterm infants, focusing on the use of Continuous Positive Airway Pressure (CPAP).", "results_summary": "The study found that CPAP was widely used in the delivery room, with 88.5% of infants in group 1 and 82.9% in group 2 receiving it. The incidence of respiratory and/or hemodynamic complications was low (8.6%), suggesting CPAP was effective in managing respiratory failure.", "population_specificity": "Moderate-to-late preterm infants (30+ weeks gestation) in neonatal intensive care units.", "effective_dosage": "Not specified", "study_duration": "Median hospitalization duration was 36 days for group 1 and 15 days for group 2.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:00.083721+00:00"}
{"study_id": 53472, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of orofacial myofunctional therapy (OMT) in treating OSA, including its potential to improve CPAP adherence and address residual OSA.", "results_summary": "The abstract highlights that CPAP may not always be effective in mild to moderate OSA, especially with non-anatomical traits, but OMT can improve outcomes like snoring, apnea-hypopnea index, and sleep quality. OMT also aids CPAP adherence and prevents residual OSA in children post-adenotonsillectomy.", "population_specificity": "Pediatric and adult OSA patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:00.404405+00:00"}
{"study_id": 53473, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to review the funding policies of clinical commissioning groups in England for the treatment of obstructive sleep apnoea, focusing on the availability of Continuous Positive Airway Pressure (CPAP) and other treatment modalities.", "results_summary": "Most clinical commissioning groups (49 of 60) funded CPAP based on clinical assessment or criteria aligned with national guidelines, while 11 offered no policy. Other treatments like mandibular advancement devices and surgeries were less consistently funded, leaving CPAP-intolerant patients with limited options in some regions.", "population_specificity": "Clinical commissioning groups in England (60 out of 190 sampled).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:02.095462+00:00"}
{"study_id": 53475, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of CPAP treatment on fatigue, sleep quality, somnolence, pain, disability, and quality of life in MS patients with OSAH.", "results_summary": "CPAP did not significantly improve the primary outcome (FSS) at 6 months but showed a trend toward improved FSS and a significant reduction in somnolence at 3 months.", "population_specificity": "MS patients with fatigue, poor subjective sleep quality, and OSAH (apnea-hypopnea index \u226515 events/hour) but without severe OSAH.", "effective_dosage": "Fixed CPAP (specific pressure not mentioned)", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:05.375513+00:00"}
{"study_id": 53476, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if prohormone levels (copeptin, proANP, proADM) could serve as diagnostic markers for OSA and indicators of response to CPAP therapy.", "results_summary": "Copeptin levels were significantly higher in OSA patients at baseline. ProADM levels changed significantly after 1 and 6 months of CPAP therapy, while proANP levels decreased after 12 hours of CPAP, suggesting acute and long-term response markers.", "population_specificity": "310 patients with suspected OSA (232 diagnosed with OSA, 30 without OSA).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:06.209324+00:00"}
{"study_id": 53474, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of noninvasive respiratory support, particularly Continuous Positive Airway Pressure (CPAP), in reducing lung injury and bronchopulmonary dysplasia in extremely preterm infants.", "results_summary": "The study highlights that CPAP has replaced invasive mechanical ventilation for initial stabilization and treatment of respiratory distress syndrome in preterm infants, but questions remain about its indiscriminate use and the need for better identification of infants suited for noninvasive support.", "population_specificity": "Extremely preterm infants, particularly those at high risk of lung injury and bronchopulmonary dysplasia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:06.599503+00:00"}
{"study_id": 53478, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to summarize current evidence on the perioperative use of CPAP therapy, particularly its effects on postoperative outcomes in patients with obstructive sleep apnea (OSA).", "results_summary": "CPAP after surgery improves oxygenation, reduces reintubation and mechanical ventilation needs, and decreases apnea/hypopnea frequency and related hypoxemia. However, poor adherence and limited high-quality studies hinder definitive conclusions.", "population_specificity": "Surgical patients with known or suspected obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:07.241161+00:00"}
{"study_id": 53479, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of Continuous Positive Airway Pressure (CPAP) in treating central sleep apnea (CSA) induced by chronic opioid use.", "results_summary": "The study found that CPAP is less effective than adaptive servo-ventilation (ASV) in reducing CSA events in chronic opioid users, but no major clinical consequences of CSA were identified. The abstract suggests CSA might be a compensatory mechanism, raising questions about the benefits of treatment.", "population_specificity": "Chronic opioid users with central sleep apnea (CSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:08.170403+00:00"}
{"study_id": 53481, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of Continuous Positive Airway Pressure (CPAP) therapy on the recurrence or progression of atrial fibrillation (AF) in patients with obstructive sleep apnea (OSA).", "results_summary": "CPAP therapy reduced the risk of AF recurrence or progression by 63% compared to non-users, with recurrence rates similar to those in non-OSA patients. The analysis included nine studies with 14,812 patients and showed statistically significant benefits.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and atrial fibrillation (AF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:10.230420+00:00"}
{"study_id": 53477, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to compare the effects of insulin detemir versus neutral protamine Hagedorn on neonatal and maternal outcomes in women with type 2 or overt type 2 diabetes mellitus, with respiratory distress (including the need for continuous positive airway pressure) as one component of the primary outcome.", "results_summary": "The study found that insulin detemir had an 87% probability of reducing adverse neonatal outcomes (including respiratory distress requiring continuous positive airway pressure) compared to neutral protamine Hagedorn. Secondary outcomes also favored insulin detemir, with lower rates of maternal hypoglycemic events and hypertensive disorders.", "population_specificity": "Women with singleton gestation and type 2 or overt type 2 diabetes mellitus seeking obstetrical care at \u226421 weeks' gestation.", "effective_dosage": "Not specified for continuous positive airway pressure (study focused on insulin regimens).", "study_duration": "Intervention duration not explicitly stated (study period was September 2018 to January 2020).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:10.398615+00:00"}
{"study_id": 53487, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to examine the effect of CPAP on ambulatory blood pressure and subclinical myocardial injury in subjects with obstructive sleep apnea and hypertension.", "results_summary": "Short-term CPAP treatment improved ambulatory blood pressure and alleviated subclinical myocardial injury and strain in subjects with OSA and difficult-to-control hypertension.", "population_specificity": "Subjects with hypertension requiring at least three antihypertensive medications and moderate-to-severe obstructive sleep apnea (75% male, mean age 51\u00b18 years).", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:14.874858+00:00"}
{"study_id": 53485, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review and compare clinical treatments and research activities for OSA, including Continuous Positive Airway Pressure, to guide patients and physicians in selecting suitable treatments.", "results_summary": "The study reviewed various OSA treatments, including CPAP, analyzing their methodologies, success rates, and economic burdens, but did not provide specific efficacy data for CPAP alone. It highlighted the need for multidisciplinary management and future research on emerging treatments like hypoglossal nerve stimulation.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:15.076939+00:00"}
{"study_id": 53482, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether combining a weight-loss Mediterranean diet/lifestyle intervention with CPAP could improve inflammation and oxidative stress markers more effectively than CPAP alone in patients with OSA.", "results_summary": "The study found that combining CPAP with a Mediterranean diet/lifestyle intervention led to greater reductions in inflammation (lower CRP levels) and oxidative stress (lower urinary 8-iso prostaglandin F2a levels) compared to CPAP alone. No changes were observed in adiponectin or oxidized guanine levels across groups.", "population_specificity": "187 overweight adults with moderate-to-severe obstructive sleep apnea (OSA).", "effective_dosage": "Not specified (standard CPAP care).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:15.179990+00:00"}
{"study_id": 53484, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not evaluate Continuous Positive Airway Pressure (CPAP); it focuses on assessing the safety and efficacy of KB109, a synthetic glycan, in outpatients with mild to moderate COVID-19.", "results_summary": "The study does not report findings related to CPAP, as it investigates KB109's impact on gut microbiota, symptom duration, and health outcomes in COVID-19 patients.", "population_specificity": "Adults \u226518 years with mild to moderate COVID-19, managed as outpatients.", "effective_dosage": "Not applicable (CPAP not studied).", "study_duration": "Not applicable (CPAP not studied).", "interactions": "None mentioned (CPAP not studied).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:15.847580+00:00"}
{"study_id": 53488, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to synthesize findings on the cost-effectiveness of CPAP for obstructive sleep apnea (OSA) and assess strategies for organizing CPAP therapy.", "results_summary": "Most studies indicated CPAP is associated with better health outcomes but at higher costs, with incremental cost-effectiveness ratios (ICER) ranging widely. CPAP was found cost-effective after the second year for moderate-to-severe OSA, and organizing care in primary care settings improved cost-effectiveness.", "population_specificity": "Patients with obstructive sleep apnea (OSA), particularly moderate-to-severe cases.", "effective_dosage": "Not specified", "study_duration": "Varied across studies, with cost-effectiveness noted after the second year of treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:16.977047+00:00"}
{"study_id": 53490, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy of prehospital CPAP versus usual care in reducing dyspnoea and respiratory rate in patients with severe acute respiratory distress.", "results_summary": "CPAP significantly reduced dyspnoea scores and respiratory rates compared to usual care, but it did not affect hospital length of stay.", "population_specificity": "Patients aged \u226540 years with acute severe respiratory distress of non-traumatic origin unresponsive to initial EMS treatments.", "effective_dosage": "Not specified", "study_duration": "Intervention duration not explicitly stated (study conducted from March 2016 to December 2018).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:18.722270+00:00"}
{"study_id": 53489, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of lung recruitment maneuvers (LRMs) on mortality and respiratory outcomes in mechanically ventilated neonates compared to routine care.", "results_summary": "The meta-analysis found no significant difference between LRMs and routine care in mortality, bronchopulmonary dysplasia, duration of supplemental oxygen, or ventilatory support. Limited evidence suggested slight improvements in end-expiratory lung volume and mean arterial pressure with specific LRMs.", "population_specificity": "Mechanically ventilated neonates, including those with respiratory distress syndrome and other respiratory/non-respiratory causes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:19.781954+00:00"}
{"study_id": 53491, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether non-benzodiazepine sedative hypnotics (NBSH) improve CPAP adherence in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found that NBSH use was associated with increased CPAP adherence, including longer nightly use (0.62 hours more) and more nights of use (12.08% increase). Eszopiclone showed the most significant effect, while zolpidem and zaleplon require further investigation.", "population_specificity": "Patients newly diagnosed with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:23.622178+00:00"}
{"study_id": 53495, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to investigate the role of gender on clinical features and 28-day mortality in Covid-19 patients, not Continuous Positive Airway Pressure.", "results_summary": "The study found that hospitalized women were less likely to die from Covid-19 compared to men, but once severe disease occurred, the risk of dying was similar. The abstract does not mention Continuous Positive Airway Pressure.", "population_specificity": "431 consecutive adult Covid-19 patients hospitalized in Bergamo, Italy.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:24.966895+00:00"}
{"study_id": 53492, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of two different nasal high-flow rates (8-10 L/min vs. 5-7 L/min) for primary respiratory support in preterm neonates with respiratory distress.", "results_summary": "Higher nasal flow rates (8-10 L/min) did not significantly reduce the need for higher respiratory support (CPAP/mechanical ventilation) or surfactant therapy compared to standard flow rates (5-7 L/min). However, standard flow rates (5 L/min) were found to be suboptimal for most preterm infants, requiring more frequent flow rate escalations.", "population_specificity": "Preterm neonates \u226528 weeks of gestation with respiratory distress from birth.", "effective_dosage": "Increased nasal flow therapy (8-10 L/min) vs. standard nasal flow therapy (5-7 L/min).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:25.364304+00:00"}
{"study_id": 53494, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the short-term efficacy and self-reported outcomes of tongue-stabilizing device (TSD) therapy versus mandibular advancement device (MAD) therapy in adults with obstructive sleep apnea.", "results_summary": "Both TSD and MAD therapies showed significant improvements in respiratory event index and oxygen saturation, but MAD therapy was more effective for daytime sleepiness and quality-of-life improvements. TSD therapy had a low treatment acceptance rate (53.8%).", "population_specificity": "Adults diagnosed with obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "2-month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:25.421726+00:00"}
{"study_id": 53493, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of bi-level noninvasive ventilation (NIV) modes, including nsNIPPV, SNIPPV, and BiPAP, versus NCPAP in reducing bronchopulmonary dysplasia (BPD), mortality, and intubation/re-intubation rates in premature infants with respiratory distress syndrome (RDS).", "results_summary": "Both nsNIPPV and SNIPPV showed reduced re-intubation and BPD rates compared to NCPAP, with SNIPPV demonstrating stronger effects. nsNIPPV also reduced intubation rates, while BiPAP showed potential benefits in one study. No significant difference in mortality was observed.", "population_specificity": "Premature infants with respiratory distress syndrome (RDS).", "effective_dosage": "Pressure settings \u2265 those used during mechanical ventilation for nsNIPPV and SNIPPV; BiPAP used two NCPAP levels \u22644 cm H2O apart.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:25.907066+00:00"}
{"study_id": 53497, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to review tools for personalizing the treatment of respiratory distress syndrome in preterm neonates, including the role of Continuous Positive Airway Pressure (CPAP) as a first-line treatment.", "results_summary": "The study found that CPAP is a first-line treatment for respiratory distress syndrome in preterm neonates, but current guidelines lack personalization. Advanced tools like lung ultrasound, surfactant assays, and oxygenation metrics show promise for individualized treatment, with lung ultrasound having the highest diagnostic accuracy.", "population_specificity": "Preterm neonates with respiratory distress syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:27.186665+00:00"}
{"study_id": 53480, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of a 12-week CPAP treatment on glycaemic control in patients with type 2 diabetes and newly detected obstructive sleep apnoea.", "results_summary": "The study found no significant changes in glycaemic control metrics (average glucose levels, time in glucose range, hypoglycaemia, hyperglycaemia, or variability) after 12 weeks of CPAP treatment. HbA1c showed a minor decrease, but the clinical relevance was unclear.", "population_specificity": "72 participants with type 2 diabetes and moderate to severe OSA (78% male, age 62 \u00b1 7, AHI 35 \u00b1 15).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:27.373219+00:00"}
{"study_id": 53498, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the immediate effect of CPAP on exercise tolerance in children with severe therapy-resistant asthma (STRA).", "results_summary": "The study found that CPAP use before physical exercise increased exercise duration in children and adolescents with STRA, with improvements noted in peak expiratory flow (PEF) and forced expiratory volume in the first second (FEV1).", "population_specificity": "Children and adolescents aged 6 to 18 years old diagnosed with severe therapy-resistant asthma (STRA).", "effective_dosage": "CPAP with PEEP 10cmH2O (specific frequency not detailed in abstract).", "study_duration": "Immediate effect (single session).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:29.154657+00:00"}
{"study_id": 53499, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effect of recumbency on nasal resistance and airflow, particularly in relation to Continuous Positive Airway Pressure therapy discontinuation and compliance.", "results_summary": "The meta-analysis found that recumbency significantly increases nasal resistance and reduces nasal airflow, which is particularly relevant for snorers and sleep apnea patients. The study included nine studies with 291 individuals, showing a statistically significant difference in nasal airway resistance.", "population_specificity": "Snorers and sleep apnea patients (291 individuals across nine studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:32.133288+00:00"}
{"study_id": 53501, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether short-term daytime CPAP application before the titration night improves polysomnographic data and CPAP adherence in patients with moderate to severe OSA.", "results_summary": "Daytime CPAP application led to significantly higher total sleep time, sleep efficiency, and time in stage N3 during the titration night, as well as better CPAP adherence at one-month follow-up compared to usual care.", "population_specificity": "Patients with moderate to severe obstructive sleep apnea (OSA) recommended for CPAP titration.", "effective_dosage": "CPAP applied for 30-60 minutes during daytime before titration night.", "study_duration": "One-month follow-up after CPAP initiation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:34.038623+00:00"}
{"study_id": 53503, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of continuous positive airway pressure (CPAP) in managing hypoxaemic respiratory failure in COVID-19 patients.", "results_summary": "The panel made a conditional recommendation for the use of CPAP in patients with hypoxaemic respiratory failure, indicating moderate efficacy but not strong enough for a definitive recommendation. The evidence supported its use alongside other interventions like high-flow nasal oxygen.", "population_specificity": "Hospitalised COVID-19 patients with hypoxaemic respiratory failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:34.117516+00:00"}
{"study_id": 53502, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess whether telemedicine interventions improve adherence to Continuous Positive Airway Pressure (CPAP) therapy in patients with obstructive sleep apnoea (OSA).", "results_summary": "The meta-analysis found that telemedicine interventions significantly improved CPAP adherence compared to controls, with a pooled mean difference of 0.57 (95% CI = 0.33 to 0.80). The effect was observed over intervention periods ranging from 1 to 6 months.", "population_specificity": "Patients with obstructive sleep apnoea (OSA).", "effective_dosage": "Not specified", "study_duration": "1 to 6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:34.185245+00:00"}
{"study_id": 53500, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between obstructive sleep apnea (OSA) and cardiovascular diseases and assess the potential role of continuous positive airway pressure (CPAP) in reducing morbidity and mortality.", "results_summary": "The study highlights that CPAP treatment for OSA is effective and suggests that screening and timely treatment could reduce cardiovascular morbidity and mortality, though the link between OSA and cardiovascular diseases remains under-recognized.", "population_specificity": "Individuals with obstructive sleep apnea, particularly those with associated cardiovascular conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:34.241201+00:00"}
{"study_id": 53505, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether CPAP therapy for obstructive sleep apnea (OSA) affects hypertension (HT).", "results_summary": "The abstract does not provide specific results but indicates that CPAP is the most common treatment for OSA, which may counteract apnea or hypopnea, and the review focuses on its potential impact on HT.", "population_specificity": "Individuals with obstructive sleep apnea (OSA) and hypertension (HT).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:35.528261+00:00"}
{"study_id": 53504, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the existing literature on perioperative non-invasive respiratory support, including CPAP, to assess its roles and outcomes in pre-, intra-, and postoperative settings.", "results_summary": "CPAP was associated with improved ventilatory variables and reduced postoperative respiratory complications preoperatively, but intraoperative data were scarce. Postoperatively, CPAP improved arterial blood gases and reduced reintubation rates, though no differences were found in mortality or other complications.", "population_specificity": "Perioperative patients, with specific subgroups noted (e.g., obesity, pregnancy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:35.551898+00:00"}
{"study_id": 53506, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the efficacy and safety of pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and OSA, including its effects on patients without continuous positive airway pressure therapy.", "results_summary": "Pitolisant significantly reduced excessive daytime sleepiness (ESS), increased mean sleep latency, and improved quality of life (EQ-5D) compared to placebo, with a higher risk of treatment-emergent adverse events (TEAEs), primarily insomnia. OSA patients benefited more, especially those not using continuous positive airway pressure therapy.", "population_specificity": "Patients with narcolepsy and Obstructive Sleep Apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:39.186329+00:00"}
{"study_id": 53507, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess the effectiveness of high-flow nasal cannulae (HFNC) compared to standard oxygen therapy or non-invasive ventilation (NIV/NIPPV, including Continuous Positive Airway Pressure) for respiratory support in adults in the ICU.", "results_summary": "HFNC may reduce treatment failure compared to standard oxygen therapy but shows little to no difference in mortality, pneumonia cases, or ICU stay length. Compared to NIV/NIPPV, HFNC likely has minimal impact on treatment failure, with most outcomes showing no significant difference, though evidence certainty was often low.", "population_specificity": "Adults admitted to the ICU, including post-extubation and non-mechanically ventilated patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:41.438268+00:00"}
{"study_id": 53510, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Continuous Positive Airway Pressure (CPAP) on blood pressure and cardiovascular outcomes in patients with obstructive sleep apnea (OSA) and hypertension.", "results_summary": "CPAP showed modest effects on blood pressure but did not reduce cardiovascular event rates in nonsleepy OSA patients. Combination strategies, including antihypertensive agents and renal denervation, may be needed for better outcomes.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and hypertension.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:41.781126+00:00"}
{"study_id": 53508, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the budget impact and resource consumption of early rescue surfactant therapy (LISA) versus CPAP alone in preterm infants with respiratory distress syndrome.", "results_summary": "Early rescue with LISA reduced resource consumption and costs compared to CPAP alone, particularly for infants born at 25-28 weeks gestation, with higher savings and a 97.4% probability of being cost-saving. The reduction in bronchopulmonary dysplasia (BPD) incidence with LISA was a key factor influencing the budget impact.", "population_specificity": "Preterm infants born at 25-32 weeks gestation with respiratory distress syndrome and fraction of inspired oxygen \u22650.3.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:42.901959+00:00"}
{"study_id": 53509, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to assess the effectiveness and compliance of Continuous Positive Airway Pressure (CPAP) therapy in patients with obstructive sleep apnea (OSA) undergoing bariatric surgery.", "results_summary": "The study found poor CPAP compliance (median 49.3% of days with use) despite improvements in OSA severity post-bariatric surgery. CPAP effectiveness was not directly measured, but OSA parameters improved significantly after surgery.", "population_specificity": "Patients with OSA undergoing bariatric surgery (median age 49.5 years, 68.2% women).", "effective_dosage": "Not specified", "study_duration": "12 months post-bariatric surgery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:42.986686+00:00"}
{"study_id": 53511, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the usefulness of helmet CPAP as a treatment, bridge to intubation, or rescue therapy for COVID-19 pneumonia patients with respiratory failure, including those with care limitations (DNI).", "results_summary": "Helmet CPAP was successful in 69% of full-treatment patients and 28% of DNI patients, improving oxygenation without requiring intubation in most cases. It was feasible for several days outside the ICU despite persistent gas exchange impairment.", "population_specificity": "COVID-19 pneumonia patients with respiratory failure failing standard oxygen therapy, including those with do-not-intubate (DNI) orders.", "effective_dosage": "Not specified", "study_duration": "Several days (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:43.678035+00:00"}
{"study_id": 53513, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine the long-term effects of CPAP treatment on cognitive deterioration in patients with obstructive sleep apnea syndrome (OSAS) and mild cognitive impairment (MCI) or Alzheimer's disease dementia (ADD).", "results_summary": "The study found that CPAP adherence was associated with a lower mean change in cognitive deterioration (measured by CDR) compared to non-adherent patients, though no significant differences were observed in MMSE scores. Overall, cognitive scores declined over time in the entire group.", "population_specificity": "Patients with MCI or ADD and comorbid OSAS.", "effective_dosage": "Not specified", "study_duration": "At least 1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:44.256251+00:00"}
{"study_id": 53512, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the pathophysiology, clinical evaluation, and management of excessive daytime sleepiness (EDS) in patients with obstructive sleep apnea (OSA) treated with continuous positive airway pressure (CPAP).", "results_summary": "CPAP therapy reduces EDS in many OSA patients, but a significant proportion continue to experience residual EDS despite optimized treatment. Wake-promoting pharmacotherapy (e.g., modafinil, solriamfetol) has shown efficacy in reducing residual EDS and improving quality of life.", "population_specificity": "Patients with obstructive sleep apnea (OSA) experiencing excessive daytime sleepiness (EDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:44.261227+00:00"}
{"study_id": 63662, "supplement_id": 1059, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review conventional and emerging treatment options, including cryotherapy, for conjunctival melanoma.", "results_summary": "The abstract mentions cryotherapy as one of the mainstays of treatment for conjunctival melanoma but does not provide specific findings on its effects.", "population_specificity": "Patients with conjunctival melanoma.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:50.935164+00:00"}
{"study_id": 63661, "supplement_id": 1059, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to review the management options for twelfth rib syndrome, including the efficacy of cryotherapy for pain relief.", "results_summary": "Cryotherapy was described as having some success in treating twelfth rib syndrome, but the evidence is limited and lacks long-term efficacy data. Surgical rib resection and nerve blocks were also noted as potential treatments.", "population_specificity": "Patients with twelfth rib syndrome experiencing chronic chest, back, flank, or abdominal pain.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:52.094586+00:00"}
{"study_id": 63658, "supplement_id": 1059, "safety_score": "85", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to determine the safety and efficacy of low-dose oral isotretinoin as adjuvant treatment for anogenital warts when combined with cryotherapy.", "results_summary": "Both cryotherapy alone and combined with isotretinoin showed 50% clearance of warts, with no significant difference in recurrence rates. Quality of life improved in both groups, and no serious adverse effects were reported.", "population_specificity": "Hispanic patients with anogenital warts.", "effective_dosage": "Cryotherapy (unspecified frequency) + isotretinoin 20 mg daily.", "study_duration": "6 weeks of treatment, followed by 4 months of follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:53.129337+00:00"}
